{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:03:47Z","timestamp":1794373427907,"version":"4.9.0"},"reference-count":478,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>At high altitudes, which typically exceed 2500\u2009m, approximately 80 million people reside permanently, with over a million visitors annually. The primary effect of high altitude is hypobaric hypoxia, which leads to decreased oxygen availability and a cascade of physiological responses. However, inadequate or excessive responses can lead to malacclimatization, resulting in hypoxemia and various high-altitude illnesses, including acute mountain sickness (AMS), high-altitude cerebral edema (HACE), high-altitude pulmonary edema (HAPE), chronic mountain sickness (CMS), and high-altitude pulmonary hypertension (HAPH). Acute altitude illnesses (AMS, HACE, and HAPE) stem from inadequate acclimatization, whereas chronic conditions (CMS and HAPH) reflect prolonged or excessive adaptive responses. This review briefly summarizes the current knowledge on the clinical manifestations, epidemiology, and risk factors for high-altitude diseases. Additionally, this review systematically discusses the most recent pathophysiological mechanisms underlying these conditions, with a special emphasis on genetic susceptibility and chronic altitude illness (CMS and HAPH). Furthermore, a comprehensive overview of current prevention and treatment strategies is provided, emphasizing the promising effects of natural medicines, especially traditional Tibetan medicines. Despite extensive research, the exact mechanisms underlying these illnesses remain elusive, and options for their management are still limited. This review aims to provide novel insights into the pathogenic mechanisms of these complex conditions and guide future research directions to improve the prevention and management of high-altitude illnesses.<\/jats:p>","DOI":"10.1038\/s41392-025-02531-1","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:03:39Z","timestamp":1769126619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Altitude hypoxia and hypoxemia: pathogenesis and management"],"prefix":"10.1038","volume":"11","author":[{"given":"Chunmei","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5296-8879","authenticated-orcid":false,"given":"Cheng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0615-7060","authenticated-orcid":false,"given":"Ri-Li","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"2531_CR1","doi-asserted-by":"publisher","first-page":"e2102463118","DOI":"10.1073\/pnas.2102463118","volume":"118","author":"JC Tremblay","year":"2021","unstructured":"Tremblay, J. C. & Ainslie, P. N. Global and country-level estimates of human population at high altitude. Proc. Natl. Acad. Sci. USA. 118, e2102463118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2531_CR2","doi-asserted-by":"publisher","first-page":"taw052","DOI":"10.1093\/jtm\/taw052","volume":"23","author":"LE Keyes","year":"2016","unstructured":"Keyes, L. E. et al. Older age, chronic medical conditions and polypharmacy in Himalayan trekkers in Nepal: an epidemiologic survey and case series. J. Travel Med. 23, taw052 (2016).","journal-title":"J. Travel Med."},{"key":"2531_CR3","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0140-6736(03)13591-X","volume":"361","author":"B Basnyat","year":"2003","unstructured":"Basnyat, B. & Murdoch, D. R. High-altitude illness. Lancet 361, 1967\u20131974 (2003).","journal-title":"Lancet"},{"key":"2531_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1056\/NEJMra2104829","volume":"386","author":"AM Luks","year":"2022","unstructured":"Luks, A. M. & Hackett, P. H. Medical conditions and high-altitude travel. N. Engl. J. Med. 386, 364\u2013373 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2531_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12929-020-00658-7","volume":"27","author":"PS Chen","year":"2020","unstructured":"Chen, P. S. et al. Pathophysiological implications of hypoxia in human diseases. J. Biomed. Sci. 27, 63 (2020).","journal-title":"J. Biomed. Sci."},{"key":"2531_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.emc.2017.01.002","volume":"35","author":"C Davis","year":"2017","unstructured":"Davis, C. & Hackett, P. Advances in the prevention and treatment of high altitude illness. Emerg. Med. Clin. North Am. 35, 241\u2013260 (2017).","journal-title":"Emerg. Med. Clin. North Am."},{"key":"2531_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev-physiol-021317-121527","volume":"81","author":"GB McClelland","year":"2019","unstructured":"McClelland, G. B. & Scott, G. R. Evolved mechanisms of aerobic performance and hypoxia resistance in high-altitude natives. Annu. Rev. Physiol. 81, 561\u2013583 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"2531_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJM200107123450206","volume":"345","author":"PH Hackett","year":"2001","unstructured":"Hackett, P. H. & Roach, R. C. High-altitude illness. N. Engl. J. Med. 345, 107\u2013114 (2001).","journal-title":"N. Engl. J. Med."},{"key":"2531_CR9","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.3390\/jcm11143937","volume":"11","author":"G Savioli","year":"2022","unstructured":"Savioli, G. et al. Pathophysiology and therapy of high-altitude sickness: practical approach in emergency and critical care. J. Clin. Med. 11, 3937 (2022).","journal-title":"J. Clin. Med."},{"key":"2531_CR10","doi-asserted-by":"publisher","first-page":"e0305651","DOI":"10.1371\/journal.pone.0305651","volume":"19","author":"JP Zila-Velasque","year":"2024","unstructured":"Zila-Velasque, J. P. et al. Mountain sickness in altitude inhabitants of Latin America: a systematic review and meta-analysis. PLoS One 19, e0305651 (2024).","journal-title":"PLoS One"},{"key":"2531_CR11","doi-asserted-by":"crossref","unstructured":"Luks, A. M., Swenson, E. R. & Bartsch, P. Acute high-altitude sickness. Eur. Respir. Rev. 26 (2017).","DOI":"10.1183\/16000617.0096-2016"},{"key":"2531_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1089\/ham.2017.0164","volume":"19","author":"RC Roach","year":"2018","unstructured":"Roach, R. C. et al. The 2018 Lake Louise acute mountain sickness score. High. Alt. Med. Biol. 19, 4\u20136 (2018).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR13","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.wem.2014.06.017","volume":"25","author":"AM Luks","year":"2014","unstructured":"Luks, A. M. et al. Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update. Wilderness Environ. Med. 25, S4\u201314 (2014).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR14","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMcp1214870","volume":"368","author":"P Bartsch","year":"2013","unstructured":"Bartsch, P. & Swenson, E. R. Clinical practice: acute high-altitude illnesses. N. Engl. J. Med. 368, 2294\u20132302 (2013).","journal-title":"N. Engl. J. Med."},{"key":"2531_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/ham.2005.6.147","volume":"6","author":"F Leon-Velarde","year":"2005","unstructured":"Leon-Velarde, F. et al. Consensus statement on chronic and subacute high altitude diseases. High. Alt. Med. Biol. 6, 147\u2013157 (2005).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR16","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1152\/physiol.00029.2021","volume":"37","author":"FC Villafuerte","year":"2022","unstructured":"Villafuerte, F. C., Simonson, T. S., Bermudez, D. & Leon-Velarde, F. High-altitude erythrocytosis: mechanisms of adaptive and maladaptive responses. Physiology 37, 0 (2022).","journal-title":"Physiology"},{"key":"2531_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.wem.2019.04.010","volume":"30","author":"HV Lankford","year":"2019","unstructured":"Lankford, H. V. High altitude deterioration: a historical essay. Wilderness Environ. Med. 30, 328\u2013333 (2019).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR18","doi-asserted-by":"crossref","unstructured":"West, J. B. High life. A history of high altitude physiology and medicine. (Oxford University Press, 1998).","DOI":"10.1007\/978-1-4614-7573-6_5"},{"key":"2531_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.7326\/0003-4819-60-5-871","volume":"60","author":"RF Fitch","year":"1964","unstructured":"Fitch, R. F. Mountain sickness: a cerebral form. Ann. Intern Med. 60, 871\u2013876 (1964).","journal-title":"Ann. Intern Med."},{"key":"2531_CR20","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.1016\/j.wem.2023.05.013","volume":"35","author":"AM Luks","year":"2024","unstructured":"Luks, A. M. et al. Wilderness medical society clinical practice guidelines for the prevention, diagnosis, and treatment of acute altitude illness: 2024 update. Wilderness Environ. Med. 35, 2S\u201319S (2024).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJM196009082631003","volume":"263","author":"CS Houston","year":"1960","unstructured":"Houston, C. S. Acute pulmonary edema of high altitude. N. Engl. J. Med. 263, 478\u2013480 (1960).","journal-title":"N. Engl. J. Med."},{"key":"2531_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.med.47.1.267","volume":"47","author":"HN Hultgren","year":"1996","unstructured":"Hultgren, H. N. High-altitude pulmonary edema: current concepts. Annu Rev. Med. 47, 267\u2013284 (1996).","journal-title":"Annu Rev. Med."},{"key":"2531_CR23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/ham.2024.0107","volume":"26","author":"RL Ge","year":"2025","unstructured":"Ge, R. L. Medical Problems of Chronic hypoxia in highlanders living on the Tibetan Plateau. High. Alt. Med. Biol. 26, 308\u2013317 (2025).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1249\/MSS.0b013e31827989ec","volume":"45","author":"BA Beidleman","year":"2013","unstructured":"Beidleman, B. A., Tighiouart, H., Schmid, C. H., Fulco, C. S. & Muza, S. R. Predictive models of acute mountain sickness after rapid ascent to various altitudes. Med. Sci. Sports Exerc 45, 792\u2013800 (2013).","journal-title":"Med. Sci. Sports Exerc"},{"key":"2531_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1089\/1527029041352054","volume":"5","author":"PH Hackett","year":"2004","unstructured":"Hackett, P. H. & Roach, R. C. High altitude cerebral edema. High. Alt. Med. Biol. 5, 136\u2013146 (2004).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1152\/japplphysiol.00861.2019","volume":"131","author":"REF Turner","year":"2021","unstructured":"Turner, R. E. F., Gatterer, H., Falla, M. & Lawley, J. S. High-altitude cerebral edema: its own entity or end-stage acute mountain sickness?. J. Appl. Physiol. 131, 313\u2013325 (2021).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1164\/rccm.201108-1396OC","volume":"185","author":"JP Richalet","year":"2012","unstructured":"Richalet, J. P., Larmignat, P., Poitrine, E., Letournel, M. & Canoui-Poitrine, F. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am. J. Respir. Crit. Care Med. 185, 192\u2013198 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2531_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ahj.2009.10.028","volume":"159","author":"JP Higgins","year":"2010","unstructured":"Higgins, J. P., Tuttle, T. & Higgins, J. A. Altitude and the heart: is going high safe for your cardiac patient?. Am. Heart J. 159, 25\u201332 (2010).","journal-title":"Am. Heart J."},{"key":"2531_CR29","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/jama.1989.03420050082044","volume":"261","author":"AB Montgomery","year":"1989","unstructured":"Montgomery, A. B., Mills, J. & Luce, J. M. Incidence of acute mountain sickness at intermediate altitude. JAMA 261, 732\u2013734 (1989).","journal-title":"JAMA"},{"key":"2531_CR30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(76)91677-9","volume":"2","author":"PH Hackett","year":"1976","unstructured":"Hackett, P. H., Rennie, D. & Levine, H. D. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 2, 1149\u20131155 (1976).","journal-title":"Lancet"},{"key":"2531_CR31","first-page":"1085","volume":"28","author":"RP Carson","year":"1969","unstructured":"Carson, R. P., Evans, W. O., Shields, J. L. & Hannon, J. P. Symptomatology, pathophysiology, and treatment of acute mountain sickness. Fed. Proc. 28, 1085\u20131091 (1969).","journal-title":"Fed. Proc."},{"key":"2531_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/bmj.301.6756.853","volume":"301","author":"M Maggiorini","year":"1990","unstructured":"Maggiorini, M., Buhler, B., Walter, M. & Oelz, O. Prevalence of acute mountain sickness in the Swiss Alps. BMJ 301, 853\u2013855 (1990).","journal-title":"BMJ"},{"key":"2531_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/ham.2008.1091","volume":"10","author":"K Mairer","year":"2009","unstructured":"Mairer, K., Wille, M., Bucher, T. & Burtscher, M. Prevalence of acute mountain sickness in the Eastern Alps. High. Alt. Med. Biol. 10, 239\u2013245 (2009).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR34","first-page":"38","volume":"6","author":"YP Hou","year":"2019","unstructured":"Hou, Y. P. et al. Sex-based differences in the prevalence of acute mountain sickness: a meta-analysis. Mil. Med. Res. 6, 38 (2019).","journal-title":"Mil. Med. Res."},{"key":"2531_CR35","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1249\/MSS.0b013e31817e91b8","volume":"40","author":"DR Wagner","year":"2008","unstructured":"Wagner, D. R. et al. Mt. Whitney: determinants of summit success and acute mountain sickness. Med. Sci. Sports Exerc 40, 1820\u20131827 (2008).","journal-title":"Med. Sci. Sports Exerc"},{"key":"2531_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.pcl.2020.09.015","volume":"68","author":"N Villca","year":"2021","unstructured":"Villca, N., Asturizaga, A. & Heath-Freudenthal, A. High-altitude illnesses and air travel: pediatric considerations. Pediatr. Clin. North Am. 68, 305\u2013319 (2021).","journal-title":"Pediatr. Clin. North Am."},{"key":"2531_CR37","doi-asserted-by":"crossref","unstructured":"Gianfredi, V., Albano, L., Basnyat, B. & Ferrara, P. Does age have an impact on acute mountain sickness? A systematic review. J. Travel Med. 27 (2020).","DOI":"10.1093\/jtm\/taz104"},{"key":"2531_CR38","first-page":"14","volume":"5","author":"Y Wu","year":"2018","unstructured":"Wu, Y., Zhang, C., Chen, Y. & Luo, Y. J. Association between acute mountain sickness (AMS) and age: a meta-analysis. Mil. Med. Res. 5, 14 (2018).","journal-title":"Mil. Med. Res."},{"key":"2531_CR39","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3357\/AMHP.4266.2015","volume":"86","author":"DM DiPasquale","year":"2015","unstructured":"DiPasquale, D. M., Strangman, G. E., Harris, N. S. & Muza, S. R. Hypoxia, hypobaria, and exercise duration affect acute mountain sickness. Aerosp. Med. Hum. Perform. 86, 614\u2013619 (2015).","journal-title":"Aerosp. Med. Hum. Perform."},{"key":"2531_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1152\/japplphysiol.00769.2012","volume":"114","author":"T Rupp","year":"2013","unstructured":"Rupp, T. et al. The effect of hypoxemia and exercise on acute mountain sickness symptoms. J. Appl. Physiol. 114, 180\u2013185 (2013).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR41","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1152\/japplphysiol.00329.2012","volume":"113","author":"K Schommer","year":"2012","unstructured":"Schommer, K. et al. Exercise intensity typical of mountain climbing does not exacerbate acute mountain sickness in normobaric hypoxia. J. Appl. Physiol. 113, 1068\u20131074 (2012).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR42","first-page":"37","volume":"3","author":"C Xu","year":"2016","unstructured":"Xu, C. et al. Association between smoking and the risk of acute mountain sickness: a meta-analysis of observational studies. Mil. Med. Res. 3, 37 (2016).","journal-title":"Mil. Med. Res."},{"key":"2531_CR43","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/thoraxjnl-2011-200623","volume":"67","author":"TY Wu","year":"2012","unstructured":"Wu, T. Y. et al. Smoking, acute mountain sickness and altitude acclimatisation: a cohort study. Thorax 67, 914\u2013919 (2012).","journal-title":"Thorax"},{"key":"2531_CR44","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1152\/japplphysiol.00879.2014","volume":"118","author":"JE Elliott","year":"2015","unstructured":"Elliott, J. E. et al. AltitudeOmics: impaired pulmonary gas exchange efficiency and blunted ventilatory acclimatization in humans with patent foramen ovale after 16 days at 5,260 m. J. Appl. Physiol. 118, 1100\u20131112 (2015).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR45","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.amjcard.2019.03.030","volume":"123","author":"BH West","year":"2019","unstructured":"West, B. H. et al. Relation of patent foramen ovale to acute mountain sickness. Am. J. Cardiol. 123, 2022\u20132025 (2019).","journal-title":"Am. J. Cardiol."},{"key":"2531_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/ham.2007.1015","volume":"8","author":"TY Wu","year":"2007","unstructured":"Wu, T. Y. et al. Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad. High. Alt. Med. Biol. 8, 88\u2013107 (2007).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1378\/chest.07-0561","volume":"134","author":"RB Schoene","year":"2008","unstructured":"Schoene, R. B. Illnesses at high altitude. Chest 134, 402\u2013416 (2008).","journal-title":"Chest"},{"key":"2531_CR48","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1161\/CIRCULATIONAHA.106.650796","volume":"116","author":"P Bartsch","year":"2007","unstructured":"Bartsch, P. & Gibbs, J. S. Effect of altitude on the heart and the lungs. Circulation 116, 2191\u20132202 (2007).","journal-title":"Circulation"},{"key":"2531_CR49","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(02)09723-4","volume":"360","author":"P Bartsch","year":"2002","unstructured":"Bartsch, P., Maggiorini, M., Mairbaurl, H., Vock, P. & Swenson, E. R. Pulmonary extravascular fluid accumulation in climbers. Lancet 360, 571 (2002).","journal-title":"Lancet"},{"key":"2531_CR50","first-page":"161","volume":"118","author":"TY Wu","year":"2005","unstructured":"Wu, T. Y. Chronic mountain sickness on the Qinghai-Tibetan plateau. Chin. Med. J. 118, 161\u2013168 (2005).","journal-title":"Chin. Med. J."},{"key":"2531_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0019-5278.130839","volume":"17","author":"IS Sahota","year":"2013","unstructured":"Sahota, I. S. & Panwar, N. S. Prevalence of Chronic Mountain Sickness in high altitude districts of Himachal Pradesh. Indian J. Occup. Environ. Med. 17, 94\u2013100 (2013).","journal-title":"Indian J. Occup. Environ. Med."},{"key":"2531_CR52","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1183\/09031936.00052606","volume":"29","author":"AM Luks","year":"2007","unstructured":"Luks, A. M. & Swenson, E. R. Travel to high altitude with pre-existing lung disease. Eur. Respir. J. 29, 770\u2013792 (2007).","journal-title":"Eur. Respir. J."},{"key":"2531_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1378\/chest.106.1.151","volume":"106","author":"F Leon-Velarde","year":"1994","unstructured":"Leon-Velarde, F., Arregui, A., Vargas, M., Huicho, L. & Acosta, R. Chronic mountain sickness and chronic lower respiratory tract disorders. Chest 106, 151\u2013155 (1994).","journal-title":"Chest"},{"key":"2531_CR54","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1089\/ham.2006.7.138","volume":"7","author":"E Vargas","year":"2006","unstructured":"Vargas, E. & Spielvogel, H. Chronic mountain sickness, optimal hemoglobin, and heart disease. High. Alt. Med. Biol. 7, 138\u2013149 (2006).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR55","unstructured":"Zubieta-Calleja, G. High altitude residents in Bolivia. Progress in mountain medicine and high altitude physiology. (1998)."},{"key":"2531_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.resp.2014.11.007","volume":"206","author":"W Guan","year":"2015","unstructured":"Guan, W. et al. Sleep disturbances in long-term immigrants with chronic mountain sickness: a comparison with healthy immigrants at high altitude. Respir. Physiol. Neurobiol. 206, 4\u201310 (2015).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"2531_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1152\/japplphysiol.00107.2016","volume":"121","author":"FC Villafuerte","year":"2016","unstructured":"Villafuerte, F. C. et al. Plasma soluble erythropoietin receptor is decreased during sleep in Andean highlanders with Chronic Mountain Sickness. J. Appl. Physiol. 121, 53\u201358 (2016).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR58","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1378\/chest.15-1450","volume":"149","author":"E Rexhaj","year":"2016","unstructured":"Rexhaj, E. et al. Sleep-disordered breathing and vascular function in patients with chronic mountain sickness and healthy high-altitude dwellers. Chest 149, 991\u2013998 (2016).","journal-title":"Chest"},{"key":"2531_CR59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1580\/1080-6032(2001)012[0002:ANPARC]2.0.CO;2","volume":"12","author":"RL Ge","year":"2001","unstructured":"Ge, R. L. et al. Atrial natriuretic peptide and red cell 2,3-diphosphoglycerate in patients with chronic mountain sickness. Wilderness Environ. Med. 12, 2\u20137 (2001).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.resp.2017.07.005","volume":"246","author":"S Sharma","year":"2017","unstructured":"Sharma, S. et al. Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge\u2019s disease). Respir. Physiol. Neurobiol. 246, 1\u20138 (2017).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"2531_CR61","unstructured":"Sutton, J. R., Houston, C. S. & Jones, N. L. Hypoxia, Exercise, and Altitude: Proceedings of the Third Banff International Hypoxia Symposium: Banff, Alberta, Canada, January 25-28, 1983. Vol. 136 (AR Liss, 1983)."},{"key":"2531_CR62","doi-asserted-by":"publisher","first-page":"443","DOI":"10.14429\/dsj.34.6088","volume":"34","author":"C Nath","year":"1984","unstructured":"Nath, C., Kashyap, S. & Subramanian, A. Chronic mountain sickness- Phobrang type. Def. Sci. J. 34, 443\u2013450 (1984).","journal-title":"Def. Sci. J."},{"key":"2531_CR63","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1056\/NEJM198911023211817","volume":"321","author":"C Monge","year":"1989","unstructured":"Monge, C., Leon-Velarde, F. & Arregui, A. Increasing prevalence of excessive erythrocytosis with age among healthy high-altitude miners. N. Engl. J. Med. 321, 1271 (1989).","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"2531_CR64","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1055\/s-2007-1024603","volume":"13","author":"CC Monge","year":"1992","unstructured":"Monge, C. C., Arregui, A. & Leon-Velarde, F. Pathophysiology and epidemiology of chronic mountain sickness. Int. J. Sports Med. 13(Suppl 1), S79\u201381 (1992).","journal-title":"Int. J. Sports Med."},{"key":"2531_CR65","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/152702901750265341","volume":"2","author":"LG Moore","year":"2001","unstructured":"Moore, L. G. Human genetic adaptation to high altitude. High. Alt. Med. Biol. 2, 257\u2013279 (2001).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR66","unstructured":"Wu, T. et al. in H. Ohno, T. Kobayashi, and S. Ma-suyama, M. Nakashima, editors. Epidemiology of chronic mountain sickness: Ten years\u2019 study in Quinghai-Tibet. In: Progress in Mountain Medicine and High Altitude Physiology. Press Committee of the Third World Congress, Matsumoto. 120-125."},{"key":"2531_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ajcn\/42.1.1","volume":"42","author":"DA Tufts","year":"1985","unstructured":"Tufts, D. A., Haas, J. D., Beard, J. L. & Spielvogel, H. Distribution of hemoglobin and functional consequences of anemia in adult males at high altitude. Am. J. Clin. Nutr. 42, 1\u201311 (1985).","journal-title":"Am. J. Clin. Nutr."},{"key":"2531_CR68","unstructured":"Ge, R. L. High Altitude Medicine (Chinese). (Peking University Medical Press, 2022)."},{"key":"2531_CR69","first-page":"90","volume":"63","author":"TY Wu","year":"1983","unstructured":"Wu, T. Y. An investigation on high altitude heart disease. Zhonghua yi xue za zhi 63, 90\u201392 (1983).","journal-title":"Zhonghua yi xue za zhi"},{"key":"2531_CR70","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/2045894020934625","volume":"10","author":"J Brito","year":"2020","unstructured":"Brito, J., Siques, P. & Pena, E. Long-term chronic intermittent hypoxia: a particular form of chronic high-altitude pulmonary hypertension. Pulm. Circ. 10, 5\u201312 (2020).","journal-title":"Pulm. Circ."},{"key":"2531_CR71","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1164\/rccm.200204-345OC","volume":"166","author":"AA Aldashev","year":"2002","unstructured":"Aldashev, A. A. et al. Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype. Am. J. Respir. Crit. Care Med. 166, 1396\u20131402 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2531_CR72","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1089\/ham.2013.1112","volume":"15","author":"PC Negi","year":"2014","unstructured":"Negi, P. C. et al. Prevalence of high altitude pulmonary hypertension among the natives of Spiti Valley-a high altitude region in Himachal Pradesh, India. High. Alt. Med. Biol. 15, 504\u2013510 (2014).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR73","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1183\/09031936.00137605","volume":"29","author":"BK Kojonazarov","year":"2007","unstructured":"Kojonazarov, B. K. et al. Noninvasive and invasive evaluation of pulmonary arterial pressure in highlanders. Eur. Respir. J. 29, 352\u2013356 (2007).","journal-title":"Eur. Respir. J."},{"key":"2531_CR74","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/ham.2020.0022","volume":"21","author":"Q Gou","year":"2020","unstructured":"Gou, Q. et al. The prevalence and risk factors of high-altitude pulmonary hypertension among native Tibetans in Sichuan Province, China. High. Alt. Med. Biol. 21, 327\u2013335 (2020).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.23907\/2018.006","volume":"8","author":"RA Kurtzman","year":"2018","unstructured":"Kurtzman, R. A. & Caruso, J. L. High-altitude illness death investigation. Acad. Forensic Pathol. 8, 83\u201397 (2018).","journal-title":"Acad. Forensic Pathol."},{"key":"2531_CR76","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4103\/ijri.IJRI_296_18","volume":"28","author":"G Medhi","year":"2018","unstructured":"Medhi, G., Lachungpa, T. & Saini, J. Neuroimaging features of fatal high-altitude cerebral edema. Indian J. Radio. Imaging 28, 401\u2013405 (2018).","journal-title":"Indian J. Radio. Imaging"},{"key":"2531_CR77","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1212\/WNL.0000000000004544","volume":"89","author":"VHR Marussi","year":"2017","unstructured":"Marussi, V. H. R. et al. Teaching NeuroImages: Typical neuroimaging features in high-altitude cerebral edema. Neurology 89, e176\u2013e177 (2017).","journal-title":"Neurology"},{"key":"2531_CR78","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/thx.38.9.646","volume":"38","author":"J Dickinson","year":"1983","unstructured":"Dickinson, J., Heath, D., Gosney, J. & Williams, D. Altitude-related deaths in seven trekkers in the Himalayas. Thorax 38, 646\u2013656 (1983).","journal-title":"Thorax"},{"key":"2531_CR79","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1580\/1080-6032(1997)008[0218:LPIHAP]2.3.CO;2","volume":"8","author":"HN Hultgren","year":"1997","unstructured":"Hultgren, H. N., Wilson, R. & Kosek, J. C. Lung pathology in high-altitude pulmonary edema. Wilderness Environ. Med. 8, 218\u2013220 (1997).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR80","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/thorax.55.2.167","volume":"55","author":"CK Grissom","year":"2000","unstructured":"Grissom, C. K., Albertine, K. H. & Elstad, M. R. Alveolar haemorrhage in a case of high altitude pulmonary oedema. Thorax 55, 167\u2013169 (2000).","journal-title":"Thorax"},{"key":"2531_CR81","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/01.CIR.29.3.393","volume":"29","author":"HN Hultgren","year":"1964","unstructured":"Hultgren, H. N., Lopez, C. E., Lundberg, E. & Miller, H. Physiologic Studies of Pulmonary Edema at High Altitude. Circulation 29, 393\u2013408 (1964).","journal-title":"Circulation"},{"key":"2531_CR82","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/ham.2017.0088","volume":"18","author":"S Baniya","year":"2017","unstructured":"Baniya, S., Holden, C. & Basnyat, B. Reentry high altitude pulmonary edema in the Himalayas. High. Alt. Med Biol. 18, 425\u2013427 (2017).","journal-title":"High. Alt. Med Biol."},{"key":"2531_CR83","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1148\/radiographics.19.6.g99no211507","volume":"19","author":"T Gluecker","year":"1999","unstructured":"Gluecker, T. et al. Clinical and radiologic features of pulmonary edema. Radiographics 19, 1507\u20131533 (1999).","journal-title":"Radiographics"},{"key":"2531_CR84","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/0002-9343(71)90181-1","volume":"50","author":"D Penaloza","year":"1971","unstructured":"Penaloza, D. & Sime, F. Chronic cor pulmonale due to loss of altitude acclimatization (chronic mountain sickness). Am. J. Med. 50, 728\u2013743 (1971).","journal-title":"Am. J. Med."},{"key":"2531_CR85","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1113\/expphysiol.2004.027698","volume":"89","author":"VE Claydon","year":"2004","unstructured":"Claydon, V. E. et al. Orthostatic tolerance and blood volumes in Andean high altitude dwellers. Exp. Physiol. 89, 565\u2013571 (2004).","journal-title":"Exp. Physiol."},{"key":"2531_CR86","doi-asserted-by":"publisher","first-page":"763835","DOI":"10.3389\/fneur.2021.763835","volume":"12","author":"H Bao","year":"2021","unstructured":"Bao, H., He, X., Wang, F. & Kang, D. Study of brain structure and function in chronic mountain sickness based on fMRI. Front. Neurol. 12, 763835 (2021).","journal-title":"Front. Neurol."},{"key":"2531_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/srep43224","volume":"7","author":"H Bao","year":"2017","unstructured":"Bao, H. et al. Cerebral edema in chronic mountain sickness: a new finding. Sci. Rep. 7, 43224 (2017).","journal-title":"Sci. Rep."},{"key":"2531_CR88","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1378\/chest.09-1355","volume":"137","author":"T Stuber","year":"2010","unstructured":"Stuber, T. et al. Exaggerated pulmonary hypertension during mild exercise in chronic mountain sickness. Chest 137, 388\u2013392 (2010).","journal-title":"Chest"},{"key":"2531_CR89","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2174\/138161282004140213125951","volume":"20","author":"AE Mirrakhimov","year":"2014","unstructured":"Mirrakhimov, A. E. & Hill, N. S. Primary antiphospholipid syndrome and pulmonary hypertension. Curr. Pharm. Des. 20, 545\u2013551 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"2531_CR90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/1874192401610010019","volume":"10","author":"AE Mirrakhimov","year":"2016","unstructured":"Mirrakhimov, A. E. & Strohl, K. P. High-altitude pulmonary hypertension: an update on disease pathogenesis and management. Open Cardiovasc Med. J. 10, 19\u201327 (2016).","journal-title":"Open Cardiovasc Med. J."},{"key":"2531_CR91","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","volume":"179","author":"MR Fisher","year":"2009","unstructured":"Fisher, M. R. et al. Accuracy of doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am. J. Respir. Crit. Care Med. 179, 615\u2013621 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2531_CR92","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/ham.2016.0024","volume":"17","author":"MJ MacInnis","year":"2016","unstructured":"MacInnis, M. J. & Koehle, M. S. Evidence for and against genetic predispositions to acute and chronic altitude illnesses. High. Alt. Med. Biol. 17, 281\u2013293 (2016).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR93","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3892\/etm.2015.2611","volume":"10","author":"LI Guo","year":"2015","unstructured":"Guo, L. I. et al. Genetic variants of endothelial PAS domain protein 1 are associated with susceptibility to acute mountain sickness in individuals unaccustomed to high altitude: A nested case-control study. Exp. Ther. Med. 10, 907\u2013914 (2015).","journal-title":"Exp. Ther. Med."},{"key":"2531_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/srep38323","volume":"6","author":"J Yu","year":"2016","unstructured":"Yu, J. et al. Analysis of high-altitude syndrome and the underlying gene polymorphisms associated with acute mountain sickness after a rapid ascent to high-altitude. Sci. Rep. 6, 38323 (2016).","journal-title":"Sci. Rep."},{"key":"2531_CR95","volume":"7","author":"JH Zhang","year":"2020","unstructured":"Zhang, J. H. et al. EPAS1 and VEGFA gene variants are related to the symptoms of acute mountain sickness in Chinese Han population: a cross-sectional study. Mil. Med. Res. 7, 35 (2020).","journal-title":"Mil. Med. Res."},{"key":"2531_CR96","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1177\/030006051204000611","volume":"40","author":"H Ding","year":"2012","unstructured":"Ding, H. et al. Associations between vascular endothelial growth factor gene polymorphisms and susceptibility to acute mountain sickness. J. Int. Med. Res. 40, 2135\u20132144 (2012).","journal-title":"J. Int. Med. Res."},{"key":"2531_CR97","doi-asserted-by":"publisher","first-page":"21777","DOI":"10.3390\/ijms151221777","volume":"15","author":"E Zhang","year":"2014","unstructured":"Zhang, E. et al. Variants of the low oxygen sensors EGLN1 and HIF-1AN associated with acute mountain sickness. Int. J. Mol. Sci. 15, 21777\u201321787 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"2531_CR98","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000322850","volume":"81","author":"H Ding","year":"2011","unstructured":"Ding, H. et al. Polymorphisms of hypoxia-related genes in subjects susceptible to acute mountain sickness. Respiration 81, 236\u2013241 (2011).","journal-title":"Respiration"},{"key":"2531_CR99","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3357\/ASEM.2361.2008","volume":"79","author":"Y Droma","year":"2008","unstructured":"Droma, Y. et al. Two hypoxia sensor genes and their association with symptoms of acute mountain sickness in Sherpas. Aviat. Space Environ. Med. 79, 1056\u20131060 (2008).","journal-title":"Aviat. Space Environ. Med."},{"key":"2531_CR100","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1089\/ham.2015.0065","volume":"16","author":"MJ MacInnis","year":"2015","unstructured":"MacInnis, M. J. et al. A Preliminary genome-wide association study of acute mountain sickness susceptibility in a group of nepalese pilgrims ascending to 4380 m. High. Alt. Med. Biol. 16, 290\u2013297 (2015).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR101","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/ham.2008.1089","volume":"10","author":"P Wang","year":"2009","unstructured":"Wang, P., Koehle, M. S. & Rupert, J. L. Genotype at the missense G894T polymorphism (Glu298Asp) in the NOS3 gene is associated with susceptibility to acute mountain sickness. High. Alt. Med. Biol. 10, 261\u2013267 (2009).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR102","first-page":"188","volume":"23","author":"CZ Jiang","year":"2005","unstructured":"Jiang, C. Z. et al. Glutathione S-transferase M1, T1 genotypes and the risk of mountain sickness. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing. Za Zhi 23, 188\u2013190 (2005).","journal-title":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing. Za Zhi"},{"key":"2531_CR103","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1089\/ham.2007.1018","volume":"8","author":"P Wang","year":"2007","unstructured":"Wang, P., Koehle, M. S. & Rupert, J. L. Common haplotypes in the beta-2 adrenergic receptor gene are not associated with acute mountain sickness susceptibility in Nepalese. High. Alt. Med. Biol. 8, 206\u2013212 (2007).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR104","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00421-008-0913-5","volume":"105","author":"NS Kalson","year":"2009","unstructured":"Kalson, N. S. et al. The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5,895 m). Eur. J. Appl. Physiol. 105, 373\u2013379 (2009).","journal-title":"Eur. J. Appl. Physiol."},{"key":"2531_CR105","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/ham.2006.7.281","volume":"7","author":"MS Koehle","year":"2006","unstructured":"Koehle, M. S., Wang, P., Guenette, J. A. & Rupert, J. L. No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 m. High. Alt. Med. Biol. 7, 281\u2013289 (2006).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR106","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00421-004-1284-1","volume":"93","author":"G Tsianos","year":"2005","unstructured":"Tsianos, G. et al. Performance at altitude and angiotensin I-converting enzyme genotype. Eur. J. Appl Physiol. 93, 630\u2013633 (2005).","journal-title":"Eur. J. Appl Physiol."},{"key":"2531_CR107","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1097\/00005768-200212000-00011","volume":"34","author":"C Dehnert","year":"2002","unstructured":"Dehnert, C. et al. No association between high-altitude tolerance and the ACE I\/D gene polymorphism. Med Sci. Sports Exerc. 34, 1928\u20131933 (2002).","journal-title":"Med Sci. Sports Exerc."},{"key":"2531_CR108","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.emc.2004.02.001","volume":"22","author":"SA Gallagher","year":"2004","unstructured":"Gallagher, S. A. & Hackett, P. H. High-altitude illness. Emerg. Med. Clin. North Am. 22, 329\u2013355 (2004). viii.","journal-title":"Emerg. Med. Clin. North Am."},{"key":"2531_CR109","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1378\/chest.126.3.825","volume":"126","author":"J Hotta","year":"2004","unstructured":"Hotta, J. et al. Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest 126, 825\u2013830 (2004).","journal-title":"Chest"},{"key":"2531_CR110","first-page":"981","volume":"75","author":"R Kumar","year":"2004","unstructured":"Kumar, R., Pasha, Q., Khan, A. P. & Gupta, V. Renin angiotensin aldosterone system and ACE I\/D gene polymorphism in high-altitude pulmonary edema. Aviat. Space Environ. Med. 75, 981\u2013983 (2004).","journal-title":"Aviat. Space Environ. Med."},{"key":"2531_CR111","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10654-007-9208-0","volume":"23","author":"Y Qi","year":"2008","unstructured":"Qi, Y., Niu, W., Zhu, T., Zhou, W. & Qiu, C. Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur. J. Epidemiol. 23, 143\u2013152 (2008).","journal-title":"Eur. J. Epidemiol."},{"key":"2531_CR112","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1620\/tjem.229.255","volume":"229","author":"QQ Wang","year":"2013","unstructured":"Wang, Q. Q. et al. Polymorphisms of angiotensin converting enzyme and nitric oxide synthase 3 genes as risk factors of high-altitude pulmonary edema: a case-control study and meta-analysis. Tohoku J. Exp. Med. 229, 255\u2013266 (2013).","journal-title":"Tohoku J. Exp. Med."},{"key":"2531_CR113","doi-asserted-by":"publisher","first-page":"11562","DOI":"10.4238\/2015.September.28.8","volume":"14","author":"AL Wu","year":"2015","unstructured":"Wu, A. L. et al. Correlation between single nucleotide polymorphisms in hypoxia-related genes and susceptibility to acute high-altitude pulmonary edema. Genet Mol. Res. 14, 11562\u201311572 (2015).","journal-title":"Genet Mol. Res."},{"key":"2531_CR114","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/1470320310387177","volume":"12","author":"T Stobdan","year":"2011","unstructured":"Stobdan, T. et al. Polymorphisms of renin-angiotensin system genes as a risk factor for high-altitude pulmonary oedema. J. Renin Angiotensin Aldosterone Syst. 12, 93\u2013101 (2011).","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"2531_CR115","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.wem.2014.09.010","volume":"26","author":"S Bhagi","year":"2015","unstructured":"Bhagi, S., Srivastava, S., Tomar, A., Bala Singh, S. & Sarkar, S. Positive association of D allele of ACE gene with high altitude pulmonary edema in indian population. Wilderness Environ. Med. 26, 124\u2013132 (2015).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR116","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/thx.2006.066019","volume":"61","author":"R Charu","year":"2006","unstructured":"Charu, R. et al. Susceptibility to high altitude pulmonary oedema: role of ACE and ET-1 polymorphisms. Thorax 61, 1011\u20131012 (2006).","journal-title":"Thorax"},{"key":"2531_CR117","doi-asserted-by":"publisher","first-page":"18961","DOI":"10.1073\/pnas.1006108107","volume":"107","author":"S Aggarwal","year":"2010","unstructured":"Aggarwal, S. et al. EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda. Proc. Natl. Acad. Sci. USA 107, 18961\u201318966 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2531_CR118","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1042\/CS20120371","volume":"124","author":"A Mishra","year":"2013","unstructured":"Mishra, A., Mohammad, G., Thinlas, T. & Pasha, M. A. EGLN1 variants influence expression and SaO2 levels to associate with high-altitude pulmonary oedema and adaptation. Clin. Sci. 124, 479\u2013489 (2013).","journal-title":"Clin. Sci."},{"key":"2531_CR119","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/152702903769192313","volume":"4","author":"J Weiss","year":"2003","unstructured":"Weiss, J. et al. Lack of evidence for association of high altitude pulmonary edema and polymorphisms of the NO pathway. High. Alt. Med. Biol. 4, 355\u2013366 (2003).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR120","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/01.CIR.0000024409.30143.70","volume":"106","author":"Y Droma","year":"2002","unstructured":"Droma, Y. et al. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation 106, 826\u2013830 (2002).","journal-title":"Circulation"},{"key":"2531_CR121","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/thx.2004.029124","volume":"59","author":"A Ahsan","year":"2004","unstructured":"Ahsan, A. et al. eNOS allelic variants at the same locus associate with HAPE and adaptation. Thorax 59, 1000\u20131002 (2004).","journal-title":"Thorax"},{"key":"2531_CR122","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1378\/chest.130.5.1511","volume":"130","author":"A Ahsan","year":"2006","unstructured":"Ahsan, A., Mohd, G., Norboo, T., Baig, M. A. & Pasha, M. A. Heterozygotes of NOS3 polymorphisms contribute to reduced nitrogen oxides in high-altitude pulmonary edema. Chest 130, 1511\u20131519 (2006).","journal-title":"Chest"},{"key":"2531_CR123","doi-asserted-by":"publisher","first-page":"6134","DOI":"10.1073\/pnas.1422759112","volume":"112","author":"A Mishra","year":"2015","unstructured":"Mishra, A. et al. Genetic differences and aberrant methylation in the apelin system predict the risk of high-altitude pulmonary edema. Proc. Natl. Acad. Sci. USA 112, 6134\u20136139 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2531_CR124","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/1470320311430990","volume":"13","author":"S Srivastava","year":"2012","unstructured":"Srivastava, S. et al. Association of polymorphisms in angiotensin and aldosterone synthase genes of the renin-angiotensin-aldosterone system with high-altitude pulmonary edema. J. Renin Angiotensin Aldosterone Syst. 13, 155\u2013160 (2012).","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"2531_CR125","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1440-1843.2010.01757.x","volume":"15","author":"T Stobdan","year":"2010","unstructured":"Stobdan, T. et al. Probable role of beta2-adrenergic receptor gene haplotype in high-altitude pulmonary oedema. Respirology 15, 651\u2013658 (2010).","journal-title":"Respirology"},{"key":"2531_CR126","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1042\/CS20110205","volume":"122","author":"A Mishra","year":"2012","unstructured":"Mishra, A. et al. CYBA and GSTP1 variants associate with oxidative stress under hypobaric hypoxia as observed in high-altitude pulmonary oedema. Clin. Sci. 122, 299\u2013309 (2012).","journal-title":"Clin. Sci."},{"key":"2531_CR127","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.wem.2013.05.006","volume":"24","author":"YZ Yang","year":"2013","unstructured":"Yang, Y. Z. et al. Endothelial PAS domain protein 1 Chr2:46441523(hg18) polymorphism is associated with susceptibility to high altitude pulmonary edema in Han Chinese. Wilderness Environ. Med 24, 315\u2013320 (2013).","journal-title":"Wilderness Environ. Med"},{"key":"2531_CR128","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2009.03.056","volume":"405","author":"Y Qi","year":"2009","unstructured":"Qi, Y. et al. Genetic interaction of Hsp70 family genes polymorphisms with high-altitude pulmonary edema among Chinese railway constructors at altitudes exceeding 4000 meters. Clin. Chim. Acta 405, 17\u201322 (2009).","journal-title":"Clin. Chim. Acta"},{"key":"2531_CR129","doi-asserted-by":"publisher","first-page":"e71993","DOI":"10.1371\/journal.pone.0071993","volume":"8","author":"N Kobayashi","year":"2013","unstructured":"Kobayashi, N. et al. Polymorphisms of the tissue inhibitor of metalloproteinase 3 gene are associated with resistance to high-altitude pulmonary edema (HAPE) in a Japanese population: a case control study using polymorphic microsatellite markers. PLoS One 8, e71993 (2013).","journal-title":"PLoS One"},{"key":"2531_CR130","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1378\/chest.128.3.1611","volume":"128","author":"S Saxena","year":"2005","unstructured":"Saxena, S. et al. Association of polymorphisms in pulmonary surfactant protein A1 and A2 genes with high-altitude pulmonary edema. Chest 128, 1611\u20131619 (2005).","journal-title":"Chest"},{"key":"2531_CR131","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/ng.3067","volume":"46","author":"FR Lorenzo","year":"2014","unstructured":"Lorenzo, F. R. et al. A genetic mechanism for Tibetan high-altitude adaptation. Nat. Genet. 46, 951\u2013956 (2014).","journal-title":"Nat. Genet."},{"key":"2531_CR132","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1126\/science.1190371","volume":"329","author":"X Yi","year":"2010","unstructured":"Yi, X. et al. Sequencing of 50 human exomes reveals adaptation to high altitude. Science 329, 75\u201378 (2010).","journal-title":"Science"},{"key":"2531_CR133","first-page":"13","volume":"90","author":"OM Mejia","year":"2005","unstructured":"Mejia, O. M., Prchal, J. T., Leon-Velarde, F., Hurtado, A. & Stockton, D. W. Genetic association analysis of chronic mountain sickness in an Andean high-altitude population. Haematologica 90, 13\u201319 (2005).","journal-title":"Haematologica"},{"key":"2531_CR134","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/ham.2014.1036","volume":"15","author":"AM Cole","year":"2014","unstructured":"Cole, A. M., Petousi, N., Cavalleri, G. L. & Robbins, P. A. Genetic variation in SENP1 and ANP32D as predictors of chronic mountain sickness. High. Alt. Med. Biol. 15, 497\u2013499 (2014).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR135","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.exphem.2016.02.010","volume":"44","author":"MM Hsieh","year":"2016","unstructured":"Hsieh, M. M. et al. SENP1, but not fetal hemoglobin, differentiates Andean highlanders with chronic mountain sickness from healthy individuals among Andean highlanders. Exp. Hematol. 44, 483\u2013490.e482 (2016).","journal-title":"Exp. Hematol."},{"key":"2531_CR136","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.cca.2010.05.043","volume":"411","author":"NE Buroker","year":"2010","unstructured":"Buroker, N. E. et al. Genetic associations with mountain sickness in Han and Tibetan residents at the Qinghai-Tibetan Plateau. Clin. Chim. Acta 411, 1466\u20131473 (2010).","journal-title":"Clin. Chim. Acta"},{"key":"2531_CR137","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/ham.2013.1121","volume":"15","author":"JR Espinoza","year":"2014","unstructured":"Espinoza, J. R. et al. Vascular endothelial growth factor-A is associated with chronic mountain sickness in the Andean population. High. Alt. Med. Biol. 15, 146\u2013154 (2014).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR138","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0140-6736(99)00206-8","volume":"353","author":"NW Morrell","year":"1999","unstructured":"Morrell, N. W., Sarybaev, A. S., Alikhan, A., Mirrakhimov, M. M. & Aldashev, A. A. ACE genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders. Lancet 353, 814 (1999).","journal-title":"Lancet"},{"key":"2531_CR139","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41431-018-0270-8","volume":"27","author":"A Iranmehr","year":"2019","unstructured":"Iranmehr, A. et al. Novel insight into the genetic basis of high-altitude pulmonary hypertension in Kyrgyz highlanders. Eur. J. Hum. Genet. 27, 150\u2013159 (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"2531_CR140","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/0002-9343(81)90834-2","volume":"70","author":"GE Gibson","year":"1981","unstructured":"Gibson, G. E., Pulsinelli, W., Blass, J. P. & Duffy, T. E. Brain dysfunction in mild to moderate hypoxia. Am. J. Med. 70, 1247\u20131254 (1981).","journal-title":"Am. J. Med."},{"key":"2531_CR141","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1471-4159.1973.tb00055.x","volume":"20","author":"JN Davis","year":"1973","unstructured":"Davis, J. N. & Carlsson, A. Effect of hypoxia on tyrosine and tryptophan hydroxylation in unanaesthetized rat brain. J. Neurochem. 20, 913\u2013915 (1973).","journal-title":"J. Neurochem."},{"key":"2531_CR142","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/j.1471-4159.1972.tb01460.x","volume":"19","author":"DB Fisher","year":"1972","unstructured":"Fisher, D. B. & Kaufman, S. The inhibition of phenylalanine and tyrosine hydroxylases by high oxygen levels. J. Neurochem. 19, 1359\u20131365 (1972).","journal-title":"J. Neurochem."},{"key":"2531_CR143","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig, H. K. & Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med. 364, 656\u2013665 (2011).","journal-title":"N. Engl. J. Med."},{"key":"2531_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/srep32426","volume":"6","author":"G Strapazzon","year":"2016","unstructured":"Strapazzon, G. et al. Oxidative stress response to acute hypobaric hypoxia and its association with indirect measurement of increased intracranial pressure: a field study. Sci. Rep. 6, 32426 (2016).","journal-title":"Sci. Rep."},{"key":"2531_CR145","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"H Sies","year":"2020","unstructured":"Sies, H. & Jones, D. P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 21, 363\u2013383 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2531_CR146","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ceb.2009.08.005","volume":"21","author":"RB Hamanaka","year":"2009","unstructured":"Hamanaka, R. B. & Chandel, N. S. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr. Opin. Cell Biol. 21, 894\u2013899 (2009).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2531_CR147","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko, M. et al. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44\u201384 (2007).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2531_CR148","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molimm.2018.02.001","volume":"95","author":"G Gong","year":"2018","unstructured":"Gong, G. et al. Ganglioside GM1 protects against high altitude cerebral edema in rats by suppressing the oxidative stress and inflammatory response via the PI3K\/AKT-Nrf2 pathway. Mol. Immunol. 95, 91\u201398 (2018).","journal-title":"Mol. Immunol."},{"key":"2531_CR149","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00421-020-04366-w","volume":"120","author":"T Debevec","year":"2020","unstructured":"Debevec, T. et al. Cardio-respiratory, oxidative stress and acute mountain sickness responses to normobaric and hypobaric hypoxia in prematurely born adults. Eur. J. Appl. Physiol. 120, 1341\u20131355 (2020).","journal-title":"Eur. J. Appl. Physiol."},{"key":"2531_CR150","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1002\/ptr.6724","volume":"34","author":"Y Pan","year":"2020","unstructured":"Pan, Y. et al. Tetrahydrocurcumin mitigates acute hypobaric hypoxia-induced cerebral oedema and inflammation through the NF-kappaB\/VEGF\/MMP-9 pathway. Phytother. Res. 34, 2963\u20132977 (2020).","journal-title":"Phytother. Res."},{"key":"2531_CR151","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.molimm.2019.02.002","volume":"108","author":"F Luan","year":"2019","unstructured":"Luan, F. et al. Phenylethanoid glycosides of Phlomis younghusbandii Mukerjee ameliorate acute hypobaric hypoxia-induced brain impairment in rats. Mol. Immunol. 108, 81\u201388 (2019).","journal-title":"Mol. Immunol."},{"key":"2531_CR152","doi-asserted-by":"publisher","first-page":"111801","DOI":"10.1016\/j.jep.2019.03.028","volume":"241","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Rhodiola crenulata attenuates apoptosis and mitochondrial energy metabolism disorder in rats with hypobaric hypoxia-induced brain injury by regulating the HIF-1alpha\/microRNA 210\/ISCU1\/2(COX10) signaling pathway. J. Ethnopharmacol. 241, 111801 (2019).","journal-title":"J. Ethnopharmacol."},{"key":"2531_CR153","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4103\/1673-5374.230291","volume":"13","author":"ZL Sun","year":"2018","unstructured":"Sun, Z. L. et al. Exendin-4 inhibits high-altitude cerebral edema by protecting against neurobiological dysfunction. Neural Regen. Res. 13, 653\u2013663 (2018).","journal-title":"Neural Regen. Res."},{"key":"2531_CR154","doi-asserted-by":"publisher","first-page":"175121","DOI":"10.1016\/j.ejphar.2022.175121","volume":"928","author":"L Jing","year":"2022","unstructured":"Jing, L., Wu, N., Zhang, J., Da, Q. & Ma, H. Protective effect of 5,6,7,8-Tetrahydroxyflavone on high altitude cerebral edema in rats. Eur. J. Pharm. 928, 175121 (2022).","journal-title":"Eur. J. Pharm."},{"key":"2531_CR155","doi-asserted-by":"publisher","first-page":"R1283","DOI":"10.1152\/ajpregu.00366.2009","volume":"297","author":"DM Bailey","year":"2009","unstructured":"Bailey, D. M. et al. Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R1283\u20131292 (2009).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2531_CR156","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/ham.2016.0119","volume":"18","author":"S Irarrazaval","year":"2017","unstructured":"Irarrazaval, S. et al. Oxidative stress in acute hypobaric hypoxia. High. Alt. Med. Biol. 18, 128\u2013134 (2017).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR157","first-page":"513","volume":"72","author":"DM Bailey","year":"2001","unstructured":"Bailey, D. M., Davies, B., Young, I. S., Hullin, D. A. & Seddon, P. S. A potential role for free radical-mediated skeletal muscle soreness in the pathophysiology of acute mountain sickness. Aviat. Space Environ. Med. 72, 513\u2013521 (2001).","journal-title":"Aviat. Space Environ. Med."},{"key":"2531_CR158","first-page":"90","volume":"7","author":"Z Radak","year":"2001","unstructured":"Radak, Z., Taylor, A. W., Ohno, H. & Goto, S. Adaptation to exercise-induced oxidative stress: from muscle to brain. Exerc. Immunol. Rev. 7, 90\u2013107 (2001).","journal-title":"Exerc. Immunol. Rev."},{"key":"2531_CR159","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1684\/ecn.2016.0383","volume":"27","author":"H Lu","year":"2016","unstructured":"Lu, H. et al. Plasma cytokine profiling to predict susceptibility to acute mountain sickness. Eur. Cytokine Netw. 27, 90\u201396 (2016).","journal-title":"Eur. Cytokine Netw."},{"key":"2531_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46391-6","volume":"9","author":"S Malacrida","year":"2019","unstructured":"Malacrida, S. et al. Transcription Factors Regulation in Human Peripheral White Blood Cells during Hypobaric Hypoxia Exposure: an in-vivo experimental study. Sci. Rep. 9, 9901 (2019).","journal-title":"Sci. Rep."},{"key":"2531_CR161","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1089\/ham.2017.0126","volume":"19","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Exploration of acute phase proteins and inflammatory cytokines in early stage diagnosis of acute mountain sickness. High. Alt. Med. Biol. 19, 170\u2013177 (2018).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR162","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fimmu.2017.00628","volume":"8","author":"B Liu","year":"2017","unstructured":"Liu, B. et al. IL-10 Dysregulation in acute mountain sickness revealed by transcriptome analysis. Front. Immunol. 8, 628 (2017).","journal-title":"Front. Immunol."},{"key":"2531_CR163","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/ham.2015.0098","volume":"17","author":"CJ Boos","year":"2016","unstructured":"Boos, C. J. et al. High altitude and acute mountain sickness and changes in circulating endothelin-1, interleukin-6, and interleukin-17a. High. Alt. Med. Biol. 17, 25\u201331 (2016).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0528-4","volume":"13","author":"TT Song","year":"2016","unstructured":"Song, T. T. et al. Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia. J. Neuroinflammation 13, 63 (2016).","journal-title":"J. Neuroinflammation"},{"key":"2531_CR165","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbi.2017.04.013","volume":"64","author":"Y Zhou","year":"2017","unstructured":"Zhou, Y. et al. Hypoxia augments LPS-induced inflammation and triggers high altitude cerebral edema in mice. Brain Behav. Immun. 64, 266\u2013275 (2017).","journal-title":"Brain Behav. Immun."},{"key":"2531_CR166","doi-asserted-by":"publisher","first-page":"mjac036","DOI":"10.1093\/jmcb\/mjac036","volume":"14","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. NRF1-mediated microglial activation triggers high-altitude cerebral edema. J. Mol. Cell Biol. 14, mjac036 (2022).","journal-title":"J. Mol. Cell Biol."},{"key":"2531_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1203-8","volume":"15","author":"F Zhao","year":"2018","unstructured":"Zhao, F. et al. Aquaporin-4 deletion ameliorates hypoglycemia-induced BBB permeability by inhibiting inflammatory responses. J. Neuroinflammation 15, 157 (2018).","journal-title":"J. Neuroinflammation"},{"key":"2531_CR168","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.lfs.2017.10.021","volume":"193","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Mechanism of aquaporin 4 (AQP 4) up-regulation in rat cerebral edema under hypobaric hypoxia and the preventative effect of puerarin. Life Sci. 193, 270\u2013281 (2018).","journal-title":"Life Sci."},{"key":"2531_CR169","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/ijms18010055","volume":"18","author":"AS Filippidis","year":"2016","unstructured":"Filippidis, A. S., Carozza, R. B. & Rekate, H. L. Aquaporins in brain edema and neuropathological conditions. Int. J. Mol. Sci. 18, 55 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"2531_CR170","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1586\/14737175.7.3.245","volume":"7","author":"M Serrano-Duenas","year":"2007","unstructured":"Serrano-Duenas, M. High-altitude headache. Expert Rev. Neurother. 7, 245\u2013248 (2007).","journal-title":"Expert Rev. Neurother."},{"key":"2531_CR171","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1474-4422(09)70014-6","volume":"8","author":"MH Wilson","year":"2009","unstructured":"Wilson, M. H., Newman, S. & Imray, C. H. The cerebral effects of ascent to high altitudes. Lancet Neurol. 8, 175\u2013191 (2009).","journal-title":"Lancet Neurol."},{"key":"2531_CR172","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/ham.2013.1138","volume":"15","author":"PN Ainslie","year":"2014","unstructured":"Ainslie, P. N. & Subudhi, A. W. Cerebral blood flow at high altitude. High. Alt. Med. Biol. 15, 133\u2013140 (2014).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR173","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/japplphysiol.00594.2013","volume":"116","author":"CK Willie","year":"2014","unstructured":"Willie, C. K. et al. Regional cerebral blood flow in humans at high altitude: gradual ascent and 2 wk at 5,050 m. J. Appl Physiol. 116, 905\u2013910 (2014).","journal-title":"J. Appl Physiol."},{"key":"2531_CR174","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1113\/expphysiol.2013.075184","volume":"99","author":"AW Subudhi","year":"2014","unstructured":"Subudhi, A. W. et al. AltitudeOmics: effect of ascent and acclimatization to 5260 m on regional cerebral oxygen delivery. Exp. Physiol. 99, 772\u2013781 (2014).","journal-title":"Exp. Physiol."},{"key":"2531_CR175","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1152\/jappl.1967.23.2.183","volume":"23","author":"PJ Cohen","year":"1967","unstructured":"Cohen, P. J., Alexander, S. C., Smith, T. C., Reivich, M. & Wollman, H. Effects of hypoxia and normocarbia on cerebral blood flow and metabolism in conscious man. J. Appl. Physiol. 23, 183\u2013189 (1967).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR176","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1172\/JCI106455","volume":"49","author":"W Shapiro","year":"1970","unstructured":"Shapiro, W., Wasserman, A. J., Baker, J. P. & Patterson, J. L. Jr Cerebrovascular response to acute hypocapnic and eucapnic hypoxia in normal man. J. Clin. Investig. 49, 2362\u20132368 (1970).","journal-title":"J. Clin. Investig."},{"key":"2531_CR177","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1152\/jappl.1996.80.4.1214","volume":"80","author":"JB Jensen","year":"1996","unstructured":"Jensen, J. B., Sperling, B., Severinghaus, J. W. & Lassen, N. A. Augmented hypoxic cerebral vasodilation in men during 5 days at 3,810 m altitude. J. Appl. Physiol. 80, 1214\u20131218 (1996).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.resp.2007.11.002","volume":"161","author":"JS Querido","year":"2008","unstructured":"Querido, J. S., Godwin, J. B. & Sheel, A. W. Intermittent hypoxia reduces cerebrovascular sensitivity to isocapnic hypoxia in humans. Respir. Physiol. Neurobiol. 161, 1\u20139 (2008).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"2531_CR179","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1164\/rccm.200903-0393OC","volume":"180","author":"KJ Reichmuth","year":"2009","unstructured":"Reichmuth, K. J. et al. Impaired vascular regulation in patients with obstructive sleep apnea: effects of continuous positive airway pressure treatment. Am. J. Respir. Crit. Care Med. 180, 1143\u20131150 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2531_CR180","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1113\/jphysiol.2012.228551","volume":"590","author":"CK Willie","year":"2012","unstructured":"Willie, C. K. et al. Regional brain blood flow in man during acute changes in arterial blood gases. J. Physiol. 590, 3261\u20133275 (2012).","journal-title":"J. Physiol."},{"key":"2531_CR181","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1152\/japplphysiol.00024.2013","volume":"114","author":"JS Querido","year":"2013","unstructured":"Querido, J. S. et al. Dynamic cerebral autoregulation during and following acute hypoxia: role of carbon dioxide. J. Appl Physiol. 114, 1183\u20131190 (2013).","journal-title":"J. Appl Physiol."},{"key":"2531_CR182","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nn2003","volume":"10","author":"C Iadecola","year":"2007","unstructured":"Iadecola, C. & Nedergaard, M. Glial regulation of the cerebral microvasculature. Nat. Neurosci. 10, 1369\u20131376 (2007).","journal-title":"Nat. Neurosci."},{"key":"2531_CR183","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nature07525","volume":"456","author":"GR Gordon","year":"2008","unstructured":"Gordon, G. R., Choi, H. B., Rungta, R. L., Ellis-Davies, G. C. & MacVicar, B. A. Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 456, 745\u2013749 (2008).","journal-title":"Nature"},{"key":"2531_CR184","first-page":"R195","volume":"242","author":"WF Nolan","year":"1982","unstructured":"Nolan, W. F., Houck, P. C., Thomas, J. L. & Davies, D. G. Ventral medullary extracellular fluid pH and blood flow during hypoxia. Am. J. Physiol. 242, R195\u2013198 (1982).","journal-title":"Am. J. Physiol."},{"key":"2531_CR185","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1042\/CS20130343","volume":"126","author":"PN Ainslie","year":"2014","unstructured":"Ainslie, P. N. et al. Stability of cerebral metabolism and substrate availability in humans during hypoxia and hyperoxia. Clin. Sci. 126, 661\u2013670 (2014).","journal-title":"Clin. Sci."},{"key":"2531_CR186","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1113\/jphysiol.2013.268953","volume":"592","author":"CK Willie","year":"2014","unstructured":"Willie, C. K., Tzeng, Y. C., Fisher, J. A. & Ainslie, P. N. Integrative regulation of human brain blood flow. J. Physiol. 592, 841\u2013859 (2014).","journal-title":"J. Physiol."},{"key":"2531_CR187","first-page":"726","volume":"65","author":"RW Baumgartner","year":"1994","unstructured":"Baumgartner, R. W., Bartsch, P., Maggiorini, M., Waber, U. & Oelz, O. Enhanced cerebral blood flow in acute mountain sickness. Aviat. Space Environ. Med. 65, 726\u2013729 (1994).","journal-title":"Aviat. Space Environ. Med."},{"key":"2531_CR188","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1152\/jappl.1999.86.5.1578","volume":"86","author":"RW Baumgartner","year":"1999","unstructured":"Baumgartner, R. W., Spyridopoulos, I., Bartsch, P., Maggiorini, M. & Oelz, O. Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study. J. Appl Physiol. 86, 1578\u20131582 (1999).","journal-title":"J. Appl Physiol."},{"key":"2531_CR189","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1152\/japplphysiol.00778.2007","volume":"104","author":"PN Ainslie","year":"2008","unstructured":"Ainslie, P. N. et al. Differential effects of acute hypoxia and high altitude on cerebral blood flow velocity and dynamic cerebral autoregulation: alterations with hyperoxia. J. Appl. Physiol. 104, 490\u2013498 (2008).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR190","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ana.23796","volume":"73","author":"MH Wilson","year":"2013","unstructured":"Wilson, M. H. et al. Cerebral venous system and anatomical predisposition to high-altitude headache. Ann. Neurol. 73, 381\u2013389 (2013).","journal-title":"Ann. Neurol."},{"key":"2531_CR191","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/0271678X15625350","volume":"37","author":"RS Sagoo","year":"2017","unstructured":"Sagoo, R. S. et al. Magnetic Resonance investigation into the mechanisms involved in the development of high-altitude cerebral edema. J. Cereb. Blood Flow. Metab. 37, 319\u2013331 (2017).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"2531_CR192","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/ana.24171","volume":"75","author":"JS Lawley","year":"2014","unstructured":"Lawley, J. S. et al. Normobaric hypoxia and symptoms of acute mountain sickness: Elevated brain volume and intracranial hypertension. Ann. Neurol. 75, 890\u2013898 (2014).","journal-title":"Ann. Neurol."},{"key":"2531_CR193","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1378\/chest.118.1.47","volume":"118","author":"J Maloney","year":"2000","unstructured":"Maloney, J., Wang, D., Duncan, T., Voelkel, N. & Ruoss, S. Plasma vascular endothelial growth factor in acute mountain sickness. Chest 118, 47\u201352 (2000).","journal-title":"Chest"},{"key":"2531_CR194","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.rmed.2006.06.014","volume":"101","author":"DA Dorward","year":"2007","unstructured":"Dorward, D. A., Thompson, A. A., Baillie, J. K., MacDougall, M. & Hirani, N. Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. Respir. Med. 101, 587\u2013594 (2007).","journal-title":"Respir. Med."},{"key":"2531_CR195","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/0974-2700.44675","volume":"2","author":"E Nilles","year":"2009","unstructured":"Nilles, E., Sayward, H. & D\u2019Onofrio, G. Vascular endothelial growth factor and acute mountain sickness. J. Emerg. Trauma Shock 2, 6\u20139 (2009).","journal-title":"J. Emerg. Trauma Shock"},{"key":"2531_CR196","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1152\/japplphysiol.00589.2004","volume":"98","author":"MC Tissot van Patot","year":"2005","unstructured":"Tissot van Patot, M. C. et al. Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. J. Appl. Physiol. 98, 1626\u20131629 (2005).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR197","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/ham.2011.1020","volume":"12","author":"K Schommer","year":"2011","unstructured":"Schommer, K., Wiesegart, N., Dehnert, C., Mairbaurl, H. & Bartsch, P. No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness. High. Alt. Med. Biol. 12, 323\u2013327 (2011).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR198","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/brain\/awf257","volume":"125","author":"HJ Schoch","year":"2002","unstructured":"Schoch, H. J., Fischer, S. & Marti, H. H. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125, 2549\u20132557 (2002).","journal-title":"Brain"},{"key":"2531_CR199","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1152\/jappl.1998.85.1.53","volume":"85","author":"F Xu","year":"1998","unstructured":"Xu, F. & Severinghaus, J. W. Rat brain VEGF expression in alveolar hypoxia: possible role in high-altitude cerebral edema. J. Appl Physiol. 85, 53\u201357 (1998).","journal-title":"J. Appl Physiol."},{"key":"2531_CR200","doi-asserted-by":"publisher","first-page":"660373","DOI":"10.3389\/fneur.2021.660373","volume":"12","author":"A Tamayo","year":"2021","unstructured":"Tamayo, A. & Siepmann, T. Regulation of blood flow in the cerebral posterior circulation by parasympathetic nerve fibers: physiological background and possible clinical implications in patients with vertebrobasilar stroke. Front. Neurol. 12, 660373 (2021).","journal-title":"Front. Neurol."},{"key":"2531_CR201","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S0140-6736(75)91053-3","volume":"2","author":"NA Lassen","year":"1975","unstructured":"Lassen, N. A. & Harper, A. M. Letter: high-altitude cerebral oedema. Lancet 2, 1154 (1975).","journal-title":"Lancet"},{"key":"2531_CR202","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/sj.jcbfm.9600384","volume":"27","author":"K Iwasaki","year":"2007","unstructured":"Iwasaki, K., Ogawa, Y., Shibata, S. & Aoki, K. Acute exposure to normobaric mild hypoxia alters dynamic relationships between blood pressure and cerebral blood flow at very low frequency. J. Cereb. Blood Flow. Metab. 27, 776\u2013784 (2007).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"2531_CR203","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/STROKEAHA.109.574749","volume":"41","author":"AW Subudhi","year":"2010","unstructured":"Subudhi, A. W., Panerai, R. B. & Roach, R. C. Effects of hypobaric hypoxia on cerebral autoregulation. Stroke 41, 641\u2013646 (2010).","journal-title":"Stroke"},{"key":"2531_CR204","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/01.STR.0000155735.85888.13","volume":"36","author":"A Van Osta","year":"2005","unstructured":"Van Osta, A. et al. Effects of high altitude exposure on cerebral hemodynamics in normal subjects. Stroke 36, 557\u2013560 (2005).","journal-title":"Stroke"},{"key":"2531_CR205","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1152\/japplphysiol.00527.2004","volume":"98","author":"JA Loeppky","year":"2005","unstructured":"Loeppky, J. A. et al. Early fluid retention and severe acute mountain sickness. J. Appl Physiol. (1985) 98, 591\u2013597 (2005).","journal-title":"J. Appl Physiol. (1985)"},{"key":"2531_CR206","doi-asserted-by":"publisher","first-page":"e73185","DOI":"10.1371\/journal.pone.0073185","volume":"8","author":"H Gatterer","year":"2013","unstructured":"Gatterer, H. et al. Association between body water status and acute mountain sickness. PLoS One 8, e73185 (2013).","journal-title":"PLoS One"},{"key":"2531_CR207","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1152\/japplphysiol.00382.2020","volume":"130","author":"J Biollaz","year":"2021","unstructured":"Biollaz, J. et al. No renal dysfunction or salt and water retention in acute mountain sickness at 4,559 m among young resting males after passive ascent. J. Appl. Physiol. 130, 226\u2013236 (2021).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR208","doi-asserted-by":"crossref","unstructured":"Regli, I. B. et al. Bioelectrical impedance vector analysis: a valuable tool to monitor daily body hydration dynamics at altitude. Int. J. Environ. Res. Public Health. 18 (2021).","DOI":"10.3390\/ijerph18105455"},{"key":"2531_CR209","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1242\/jeb.204.18.3161","volume":"204","author":"RC Roach","year":"2001","unstructured":"Roach, R. C. & Hackett, P. H. Frontiers of hypoxia research: acute mountain sickness. J. Exp. Biol. 204, 3161\u20133170 (2001).","journal-title":"J. Exp. Biol."},{"key":"2531_CR210","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1152\/jappl.1991.71.1.136","volume":"71","author":"P Bartsch","year":"1991","unstructured":"Bartsch, P. et al. Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness. J. Appl Physiol. 71, 136\u2013143 (1991).","journal-title":"J. Appl Physiol."},{"key":"2531_CR211","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1152\/japplphysiol.00936.2001","volume":"92","author":"MH Bestle","year":"2002","unstructured":"Bestle, M. H. et al. Prolonged hypobaric hypoxemia attenuates vasopressin secretion and renal response to osmostimulation in men. J. Appl Physiol. 92, 1911\u20131922 (2002).","journal-title":"J. Appl Physiol."},{"key":"2531_CR212","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1089\/ham.2017.0056","volume":"18","author":"G Strapazzon","year":"2017","unstructured":"Strapazzon, G. et al. Total body water dynamics estimated with bioelectrical impedance vector analysis and B-type natriuretic peptide after exposure to hypobaric hypoxia: a field study. High. Alt. Med. Biol. 18, 384\u2013391 (2017).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR213","doi-asserted-by":"publisher","first-page":"779","DOI":"10.33549\/physiolres.931032","volume":"56","author":"B Haditsch","year":"2007","unstructured":"Haditsch, B., Roessler, A. & Hinghofer-Szalkay, H. G. Renal adrenomedullin and high altitude diuresis. Physiol. Res. 56, 779\u2013787 (2007).","journal-title":"Physiol. Res."},{"key":"2531_CR214","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3357\/ASEM.2390.2009","volume":"80","author":"B Feddersen","year":"2009","unstructured":"Feddersen, B. et al. Brain natriuretic peptide at altitude: relationship to diuresis, natriuresis, and mountain sickness. Aviat. Space Environ. Med. 80, 108\u2013111 (2009).","journal-title":"Aviat. Space Environ. Med."},{"key":"2531_CR215","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1007\/s00421-011-1881-8","volume":"111","author":"D Woods","year":"2011","unstructured":"Woods, D. et al. Effects of altitude exposure on brain natriuretic peptide in humans. Eur. J. Appl. Physiol. 111, 2687\u20132693 (2011).","journal-title":"Eur. J. Appl. Physiol."},{"key":"2531_CR216","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/ham.2014.1035","volume":"15","author":"A Mellor","year":"2014","unstructured":"Mellor, A. et al. Cardiac biomarkers at high altitude. High. Alt. Med. Biol. 15, 452\u2013458 (2014).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR217","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1580\/07-WEME-REV-173.1","volume":"19","author":"JO Stream","year":"2008","unstructured":"Stream, J. O. & Grissom, C. K. Update on high-altitude pulmonary edema: pathogenesis, prevention, and treatment. Wilderness Environ. Med. 19, 293\u2013303 (2008).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR218","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1161\/01.CIR.99.13.1713","volume":"99","author":"H Duplain","year":"1999","unstructured":"Duplain, H. et al. Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation 99, 1713\u20131718 (1999).","journal-title":"Circulation"},{"key":"2531_CR219","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1055\/s-2007-1024599","volume":"13","author":"PH Hackett","year":"1992","unstructured":"Hackett, P. H., Roach, R. C., Hartig, G. S., Greene, E. R. & Levine, B. D. The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: a comparison. Int. J. Sports Med. 13, S68\u201371 (1992).","journal-title":"Int. J. Sports Med."},{"key":"2531_CR220","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.pharmthera.2004.11.009","volume":"106","author":"C Sartori","year":"2005","unstructured":"Sartori, C., Lepori, M. & Scherrer, U. Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans. Pharm. Ther. 106, 209\u2013220 (2005).","journal-title":"Pharm. Ther."},{"key":"2531_CR221","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.bbagen.2014.01.015","volume":"1840","author":"M Singh","year":"2014","unstructured":"Singh, M., Padhy, G., Vats, P., Bhargava, K. & Sethy, N. K. Hypobaric hypoxia induced arginase expression limits nitric oxide availability and signaling in rodent heart. Biochim. Biophys. Acta 1840, 1817\u20131824 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"2531_CR222","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.freeradbiomed.2011.12.028","volume":"52","author":"CM Beall","year":"2012","unstructured":"Beall, C. M., Laskowski, D. & Erzurum, S. C. Nitric oxide in adaptation to altitude. Free Radic. Biol. Med 52, 1123\u20131134 (2012).","journal-title":"Free Radic. Biol. Med"},{"key":"2531_CR223","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1016\/j.cell.2022.06.010","volume":"185","author":"JO Lundberg","year":"2022","unstructured":"Lundberg, J. O. & Weitzberg, E. Nitric oxide signaling in health and disease. Cell 185, 2853\u20132878 (2022).","journal-title":"Cell"},{"key":"2531_CR224","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.plaphy.2022.05.017","volume":"184","author":"SK Kohli","year":"2022","unstructured":"Kohli, S. K., Khanna, K., Bhardwaj, R., Corpas, F. J. & Ahmad, P. Nitric oxide, salicylic acid and oxidative stress: Is it a perfect equilateral triangle?. Plant Physiol. Biochem. 184, 56\u201364 (2022).","journal-title":"Plant Physiol. Biochem."},{"key":"2531_CR225","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/35106641","volume":"414","author":"CM Beall","year":"2001","unstructured":"Beall, C. M. et al. Pulmonary nitric oxide in mountain dwellers. Nature 414, 411\u2013412 (2001).","journal-title":"Nature"},{"key":"2531_CR226","doi-asserted-by":"publisher","first-page":"17593","DOI":"10.1073\/pnas.0707462104","volume":"104","author":"SC Erzurum","year":"2007","unstructured":"Erzurum, S. C. et al. Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc. Natl. Acad. Sci. USA 104, 17593\u201317598 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2531_CR227","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1056\/NEJMc1107887","volume":"365","author":"AJ Janocha","year":"2011","unstructured":"Janocha, A. J. et al. Nitric oxide during altitude acclimatization. N. Engl. J. Med. 365, 1942\u20131944 (2011).","journal-title":"N. Engl. J. Med."},{"key":"2531_CR228","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1164\/ajrccm.163.2.2001134","volume":"163","author":"T Busch","year":"2001","unstructured":"Busch, T. et al. Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am. J. Respir. Crit. Care Med. 163, 368\u2013373 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2531_CR229","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1164\/ajrccm.162.1.9908039","volume":"162","author":"H Duplain","year":"2000","unstructured":"Duplain, H. et al. Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am. J. Respir. Crit. Care Med. 162, 221\u2013224 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2531_CR230","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1056\/NEJM199603073341003","volume":"334","author":"U Scherrer","year":"1996","unstructured":"Scherrer, U. et al. Inhaled nitric oxide for high-altitude pulmonary edema. N. Engl. J. Med. 334, 624\u2013629 (1996).","journal-title":"N. Engl. J. Med."},{"key":"2531_CR231","doi-asserted-by":"publisher","first-page":"497","DOI":"10.7326\/0003-4819-145-7-200610030-00007","volume":"145","author":"M Maggiorini","year":"2006","unstructured":"Maggiorini, M. et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann. Intern Med. 145, 497\u2013506 (2006).","journal-title":"Ann. Intern Med."},{"key":"2531_CR232","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/01.CIR.91.2.359","volume":"91","author":"S Goerre","year":"1995","unstructured":"Goerre, S. et al. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 91, 359\u2013364 (1995).","journal-title":"Circulation"},{"key":"2531_CR233","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1161\/01.CIR.99.20.2665","volume":"99","author":"C Sartori","year":"1999","unstructured":"Sartori, C. et al. Exaggerated endothelin release in high-altitude pulmonary edema. Circulation 99, 2665\u20132668 (1999).","journal-title":"Circulation"},{"key":"2531_CR234","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/ham.2008.1053","volume":"10","author":"MM Berger","year":"2009","unstructured":"Berger, M. M. et al. Transpulmonary plasma ET-1 and nitrite differences in high altitude pulmonary hypertension. High. Alt. Med. Biol. 10, 17\u201324 (2009).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR235","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1161\/CIRCULATIONAHA.105.605527","volume":"114","author":"PA Modesti","year":"2006","unstructured":"Modesti, P. A. et al. Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study. Circulation 114, 1410\u20131416 (2006).","journal-title":"Circulation"},{"key":"2531_CR236","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2362.2010.02254.x","volume":"40","author":"I Pham","year":"2010","unstructured":"Pham, I., Wuerzner, G., Richalet, J. P., Peyrard, S. & Azizi, M. Endothelin receptors blockade blunts hypoxia-induced increase in PAP in humans. Eur. J. Clin. Investig. 40, 195\u2013202 (2010).","journal-title":"Eur. J. Clin. Investig."},{"key":"2531_CR237","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1172\/JCI116604","volume":"92","author":"S Kourembanas","year":"1993","unstructured":"Kourembanas, S., McQuillan, L. P., Leung, G. K. & Faller, D. V. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Investig. 92, 99\u2013104 (1993).","journal-title":"J. Clin. Investig."},{"key":"2531_CR238","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/ham.2013.1010","volume":"14","author":"ER Swenson","year":"2013","unstructured":"Swenson, E. R. Hypoxic pulmonary vasoconstriction. High. Alt. Med. Biol. 14, 101\u2013110 (2013).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR239","doi-asserted-by":"publisher","first-page":"148431","DOI":"10.1016\/j.bbabio.2021.148431","volume":"1862","author":"S Sharma","year":"2021","unstructured":"Sharma, S. et al. Mitochondrial DNA mutations contribute to high altitude pulmonary edema via increased oxidative stress and metabolic reprogramming during hypobaric hypoxia. Biochim. Biophys. Acta Bioenerg. 1862, 148431 (2021).","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"2531_CR240","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.1113\/jphysiol.2010.194704","volume":"588","author":"DM Bailey","year":"2010","unstructured":"Bailey, D. M. et al. High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability. J. Physiol. 588, 4837\u20134847 (2010).","journal-title":"J. Physiol."},{"key":"2531_CR241","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3181\/0712-RM-337","volume":"233","author":"S Sarada","year":"2008","unstructured":"Sarada, S. et al. Role of oxidative stress and NFkB in hypoxia-induced pulmonary edema. Exp. Biol. Med. 233, 1088\u20131098 (2008).","journal-title":"Exp. Biol. Med."},{"key":"2531_CR242","doi-asserted-by":"publisher","first-page":"L837","DOI":"10.1152\/ajplung.90608.2008","volume":"297","author":"U Pfeil","year":"2009","unstructured":"Pfeil, U. et al. Intermedin\/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L837\u2013845 (2009).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR243","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1152\/jappl.1988.64.6.2605","volume":"64","author":"RB Schoene","year":"1988","unstructured":"Schoene, R. B. et al. The lung at high altitude: bronchoalveolar lavage in acute mountain sickness and pulmonary edema. J. Appl. Physiol. 64, 2605\u20132613 (1988).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR244","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12291-015-0491-3","volume":"31","author":"KP Mishra","year":"2016","unstructured":"Mishra, K. P. et al. Hypoxia-induced inflammatory chemokines in subjects with a history of high-altitude pulmonary edema. Indian J. Clin. Biochem. 31, 81\u201386 (2016).","journal-title":"Indian J. Clin. Biochem."},{"key":"2531_CR245","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1001\/jama.287.17.2228","volume":"287","author":"ER Swenson","year":"2002","unstructured":"Swenson, E. R. et al. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 287, 2228\u20132235 (2002).","journal-title":"JAMA"},{"key":"2531_CR246","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1378\/chest.117.5.1393","volume":"117","author":"P Bartsch","year":"2000","unstructured":"Bartsch, P. et al. Urinary leukotriene E(4) levels are not increased prior to high-altitude pulmonary edema. Chest 117, 1393\u20131398 (2000).","journal-title":"Chest"},{"key":"2531_CR247","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1152\/jappl.1996.81.5.1917","volume":"81","author":"GR Kleger","year":"1996","unstructured":"Kleger, G. R. et al. Evidence against an increase in capillary permeability in subjects exposed to high altitude. J. Appl. Physiol. 81, 1917\u20131923 (1996).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR248","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejphar.2011.01.038","volume":"656","author":"D Shukla","year":"2011","unstructured":"Shukla, D. et al. Hypoxic preconditioning with cobalt ameliorates hypobaric hypoxia induced pulmonary edema in rat. Eur. J. Pharm. 656, 101\u2013109 (2011).","journal-title":"Eur. J. Pharm."},{"key":"2531_CR249","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/j.2040-4603.2012.tb00459.x","volume":"2","author":"ER Swenson","year":"2012","unstructured":"Swenson, E. R. & Bartsch, P. High-altitude pulmonary edema. Compr. Physiol. 2, 2753\u20132773 (2012).","journal-title":"Compr. Physiol."},{"key":"2531_CR250","doi-asserted-by":"publisher","first-page":"111669","DOI":"10.1016\/j.biopha.2021.111669","volume":"139","author":"J Shi","year":"2021","unstructured":"Shi, J. et al. Polysaccharide from Potentilla anserina L ameliorate pulmonary edema induced by hypobaric hypoxia in rats. Biomed. Pharmacother. 139, 111669 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"2531_CR251","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219075","volume":"14","author":"A Tripathi","year":"2019","unstructured":"Tripathi, A., Kumar, B. & Sagi, S. S. K. Prophylactic efficacy of Quercetin in ameliorating the hypoxia induced vascular leakage in lungs of rats. PLoS One 14, e0219075 (2019).","journal-title":"PLoS One"},{"key":"2531_CR252","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1378\/chest.123.1.49","volume":"123","author":"AL Gabry","year":"2003","unstructured":"Gabry, A. L., Ledoux, X., Mozziconacci, M. & Martin, C. High-altitude pulmonary edema at moderate altitude (< 2400 m; 7870 feet): a series of 52 patients. Chest 123, 49\u201353 (2003).","journal-title":"Chest"},{"key":"2531_CR253","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1152\/jappl.1993.74.4.1534","volume":"74","author":"S Ono","year":"1993","unstructured":"Ono, S., Westcott, J. Y., Chang, S. W. & Voelkel, N. F. Endotoxin priming followed by high altitude causes pulmonary edema in rats. J. Appl. Physiol. 74, 1534\u20131542 (1993).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR254","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1152\/jappl.1998.84.3.1048","volume":"84","author":"TC Carpenter","year":"1998","unstructured":"Carpenter, T. C., Reeves, J. T. & Durmowicz, A. G. Viral respiratory infection increases susceptibility of young rats to hypoxia-induced pulmonary edema. J. Appl. Physiol. 84, 1048\u20131054 (1998).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR255","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pcad.2010.02.004","volume":"52","author":"U Scherrer","year":"2010","unstructured":"Scherrer, U., Rexhaj, E., Jayet, P. Y., Allemann, Y. & Sartori, C. New insights in the pathogenesis of high-altitude pulmonary edema. Prog. Cardiovasc. Dis. 52, 485\u2013492 (2010).","journal-title":"Prog. Cardiovasc. Dis."},{"key":"2531_CR256","doi-asserted-by":"publisher","first-page":"L685","DOI":"10.1152\/ajplung.00247.2005","volume":"289","author":"GM Mutlu","year":"2005","unstructured":"Mutlu, G. M. & Sznajder, J. I. Mechanisms of pulmonary edema clearance. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L685\u2013695 (2005).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR257","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1172\/JCI8258","volume":"105","author":"T Ma","year":"2000","unstructured":"Ma, T., Fukuda, N., Song, Y., Matthay, M. A. & Verkman, A. S. Lung fluid transport in aquaporin-5 knockout mice. J. Clin. Investig. 105, 93\u2013100 (2000).","journal-title":"J. Clin. Investig."},{"key":"2531_CR258","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1056\/NEJMoa013183","volume":"346","author":"C Sartori","year":"2002","unstructured":"Sartori, C. et al. Salmeterol for the prevention of high-altitude pulmonary edema. N. Engl. J. Med 346, 1631\u20131636 (2002).","journal-title":"N. Engl. J. Med"},{"key":"2531_CR259","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1183\/09031936.04.00115304","volume":"23","author":"C Sartori","year":"2004","unstructured":"Sartori, C. et al. High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects. Eur. Respir. J. 23, 916\u2013920 (2004).","journal-title":"Eur. Respir. J."},{"key":"2531_CR260","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/bja\/87.6.897","volume":"87","author":"B Nagyova","year":"2001","unstructured":"Nagyova, B., O\u2019Neill, M. & Dorrington, K. L. Inhibition of active sodium absorption leads to a net liquid secretion into in vivo rabbit lung at two levels of alveolar hypoxia. Br. J. Anaesth. 87, 897\u2013904 (2001).","journal-title":"Br. J. Anaesth."},{"key":"2531_CR261","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1165\/ajrcmb.25.5.4420","volume":"25","author":"ML Vivona","year":"2001","unstructured":"Vivona, M. L., Matthay, M., Chabaud, M. B., Friedlander, G. & Clerici, C. Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by beta-adrenergic agonist treatment. Am. J. Respir. Cell Mol. Biol. 25, 554\u2013561 (2001).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2531_CR262","doi-asserted-by":"publisher","first-page":"L500","DOI":"10.1152\/ajplung.90390.2008","volume":"296","author":"E Baloglu","year":"2009","unstructured":"Baloglu, E., Ke, A., Abu-Taha, I. H., Bartsch, P. & Mairbaurl, H. In vitro hypoxia impairs beta2-adrenergic receptor signaling in primary rat alveolar epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 296, L500\u2013509 (2009).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR263","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1152\/jappl.1988.65.2.585","volume":"65","author":"Y Berthiaume","year":"1988","unstructured":"Berthiaume, Y., Broaddus, V. C., Gropper, M. A., Tanita, T. & Matthay, M. A. Alveolar liquid and protein clearance from normal dog lungs. J. Appl. Physiol. 65, 585\u2013593 (1988).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR264","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1172\/JCI112817","volume":"79","author":"Y Berthiaume","year":"1987","unstructured":"Berthiaume, Y., Staub, N. C. & Matthay, M. A. Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J. Clin. Investig. 79, 335\u2013343 (1987).","journal-title":"J. Clin. Investig."},{"key":"2531_CR265","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1746-1596-8-193","volume":"8","author":"J She","year":"2013","unstructured":"She, J., Bi, J., Tong, L., Song, Y. & Bai, C. New insights of aquaporin 5 in the pathogenesis of high altitude pulmonary edema. Diagn. Pathol. 8, 193 (2013).","journal-title":"Diagn. Pathol."},{"key":"2531_CR266","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1113\/jphysiol.2004.066704","volume":"560","author":"M Egli","year":"2004","unstructured":"Egli, M. et al. Defective respiratory amiloride-sensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice. J. Physiol. 560, 857\u2013865 (2004).","journal-title":"J. Physiol."},{"key":"2531_CR267","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1183\/09031936.02.00222302","volume":"20","author":"CC Christensen","year":"2002","unstructured":"Christensen, C. C., Ryg, M. S., Refvem, O. K. & Skjonsberg, O. H. Effect of hypobaric hypoxia on blood gases in patients with restrictive lung disease. Eur. Respir. J. 20, 300\u2013305 (2002).","journal-title":"Eur. Respir. J."},{"key":"2531_CR268","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1152\/jappl.1965.20.5.1026","volume":"20","author":"R Lozano","year":"1965","unstructured":"Lozano, R. & Monge, C. Renal function in high-altitude natives and in natives with chronic mountain sickness. J. Appl. Physiol. 20, 1026\u20131027 (1965).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR269","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000194097","volume":"38","author":"JC Cruz","year":"1979","unstructured":"Cruz, J. C., Diaz, C., Marticorena, E. & Hilario, V. Phlebotomy improves pulmonary gas exchange in chronic mountain polycythemia. Respiration 38, 305\u2013313 (1979).","journal-title":"Respiration"},{"key":"2531_CR270","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1152\/japplphysiol.00858.2002","volume":"94","author":"F Leon-Velarde","year":"2003","unstructured":"Leon-Velarde, F., Gamboa, A., Rivera-Ch, M., Palacios, J. A. & Robbins, P. A. Selected contribution: Peripheral chemoreflex function in high-altitude natives and patients with chronic mountain sickness. J. Appl. Physiol. 94, 1269\u20131278 (2003).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR271","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fphys.2020.00437","volume":"11","author":"EC Heinrich","year":"2020","unstructured":"Heinrich, E. C. et al. Relationships between chemoreflex responses, sleep quality, and hematocrit in Andean men and women. Front Physiol. 11, 437 (2020).","journal-title":"Front Physiol."},{"key":"2531_CR272","first-page":"197","volume":"31","author":"YM Gao","year":"2023","unstructured":"Gao, Y. M. et al. Expression of Key Enzymes in Glucose Metabolism in Chronic Mountain Sickness and Its Correlation with Phenotype. Zhongguo Shi Yan Xue Ye Xue Za Zhi 31, 197\u2013202 (2023).","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"2531_CR273","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-med-042921-102602","volume":"74","author":"GL Semenza","year":"2023","unstructured":"Semenza, G. L. Regulation of Erythropoiesis by the Hypoxia-Inducible Factor Pathway: Effects of Genetic and Pharmacological Perturbations. Annu Rev. Med 74, 307\u2013319 (2023).","journal-title":"Annu Rev. Med"},{"key":"2531_CR274","first-page":"2670","volume":"99","author":"HH Liu","year":"2019","unstructured":"Liu, H. H., Su, J., Ma, J., Li, Z. Q. & Ge, R. L. The expression of VHL\/HIF signaling pathway in the erythroid progenitor cells with chronic mountain sickness. Zhonghua Yi Xue Za Zhi 99, 2670\u20132674 (2019).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2531_CR275","doi-asserted-by":"crossref","unstructured":"Zhou, S., Yan, J., Song, K. & Ge, R. L. High-altitude hypoxia induces excessive erythrocytosis in mice via upregulation of the intestinal HIF2a\/iron-metabolism pathway. Biomedicines. 11 (2023).","DOI":"10.3390\/biomedicines11112992"},{"key":"2531_CR276","first-page":"121","volume":"35","author":"J Su","year":"2018","unstructured":"Su, J. The expressions of VEGF and VEGFR signaling pathway in the bone marrow mononuclear cells with chronic mountain sickness. China Med. Abstr. 35, 121 (2018).","journal-title":"China Med. Abstr."},{"key":"2531_CR277","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/cells10082140","volume":"10","author":"AS Tsiftsoglou","year":"2021","unstructured":"Tsiftsoglou, A. S. Erythropoietin (EPO) as a key regulator of erythropoiesis, bone remodeling and endothelial transdifferentiation of multipotent mesenchymal stem cells (MSCs): implications in regenerative medicine. Cells. 10, 2140 (2021).","journal-title":"Cells"},{"key":"2531_CR278","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.12659\/MSM.905739","volume":"23","author":"C Zhao","year":"2017","unstructured":"Zhao, C. et al. PI3K-Akt signal transduction molecules maybe involved in downregulation of erythroblasts apoptosis and perifosine increased its apoptosis in chronic mountain sickness. Med. Sci. Monit. 23, 5637\u20135649 (2017).","journal-title":"Med. Sci. Monit."},{"key":"2531_CR279","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1152\/japplphysiol.00619.2014","volume":"117","author":"FC Villafuerte","year":"2014","unstructured":"Villafuerte, F. C. et al. Decreased plasma soluble erythropoietin receptor in high-altitude excessive erythrocytosis and Chronic Mountain Sickness. J. Appl. Physiol. 117, 1356\u20131362 (2014).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR280","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1152\/ajpregu.00250.2019","volume":"318","author":"D Bermudez","year":"2020","unstructured":"Bermudez, D. et al. Increased hypoxic proliferative response and gene expression in erythroid progenitor cells of Andean highlanders with chronic mountain sickness. Am. J. Physiol. Regul. Integr. Comp. Physiol. 318, R49\u2013R56 (2020).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2531_CR281","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1378\/chest.12-0728","volume":"143","author":"DM Bailey","year":"2013","unstructured":"Bailey, D. M. et al. Oxidative-nitrosative stress and systemic vascular function in highlanders with and without exaggerated hypoxemia. Chest 143, 444\u2013451 (2013).","journal-title":"Chest"},{"key":"2531_CR282","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1113\/JP276898","volume":"597","author":"DM Bailey","year":"2019","unstructured":"Bailey, D. M. et al. Exaggerated systemic oxidative-inflammatory-nitrosative stress in chronic mountain sickness is associated with cognitive decline and depression. J. Physiol. 597, 611\u2013629 (2019).","journal-title":"J. Physiol."},{"key":"2531_CR283","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4103\/0973-1296.141817","volume":"10","author":"D Maimaitiyiming","year":"2014","unstructured":"Maimaitiyiming, D., Hu, G., Aikemu, A., Hui, S. W. & Zhang, X. The treatment of Uygur medicine Dracocephalum moldavica L on chronic mountain sickness rat model. Pharmacogn. Mag. 10, 477\u2013482 (2014).","journal-title":"Pharmacogn. Mag."},{"key":"2531_CR284","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.resp.2013.01.016","volume":"186","author":"CG Julian","year":"2013","unstructured":"Julian, C. G. et al. Sleep-disordered breathing and oxidative stress in preclinical chronic mountain sickness (excessive erythrocytosis). Respir. Physiol. Neurobiol. 186, 188\u2013196 (2013).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"2531_CR285","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/ham.2022.0151","volume":"24","author":"M Qile","year":"2023","unstructured":"Qile, M. et al. Erythrocytes display metabolic changes in high-altitude polycythemia. High. Alt. Med. Biol. 24, 104\u2013109 (2023).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR286","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.106.624544","volume":"115","author":"D Penaloza","year":"2007","unstructured":"Penaloza, D. & Arias-Stella, J. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Circulation 115, 1132\u20131146 (2007).","journal-title":"Circulation"},{"key":"2531_CR287","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1161\/01.CIR.0000062688.76508.B3","volume":"107","author":"ZI Pozeg","year":"2003","unstructured":"Pozeg, Z. I. et al. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats. Circulation 107, 2037\u20132044 (2003).","journal-title":"Circulation"},{"key":"2531_CR288","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/hc0202.101974","volume":"105","author":"ED Michelakis","year":"2002","unstructured":"Michelakis, E. D. et al. Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation 105, 244\u2013250 (2002).","journal-title":"Circulation"},{"key":"2531_CR289","doi-asserted-by":"publisher","first-page":"L801","DOI":"10.1152\/ajplung.2001.280.4.L801","volume":"280","author":"O Platoshyn","year":"2001","unstructured":"Platoshyn, O. et al. Chronic hypoxia decreases K(V) channel expression and function in pulmonary artery myocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 280, L801\u2013812 (2001).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR290","first-page":"L116","volume":"264","author":"XJ Yuan","year":"1993","unstructured":"Yuan, X. J., Goldman, W. F., Tod, M. L., Rubin, L. J. & Blaustein, M. P. Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am. J. Physiol. 264, L116\u2013123 (1993).","journal-title":"Am. J. Physiol."},{"key":"2531_CR291","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/hh1301.093616","volume":"89","author":"M Dipp","year":"2001","unstructured":"Dipp, M. & Evans, A. M. Cyclic ADP-ribose is the primary trigger for hypoxic pulmonary vasoconstriction in the rat lung in situ. Circ. Res. 89, 77\u201383 (2001).","journal-title":"Circ. Res."},{"key":"2531_CR292","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bjp.0701326","volume":"122","author":"RI Jabr","year":"1997","unstructured":"Jabr, R. I., Toland, H., Gelband, C. H., Wang, X. X. & Hume, J. R. Prominent role of intracellular Ca2+ release in hypoxic vasoconstriction of canine pulmonary artery. Br. J. Pharm. 122, 21\u201330 (1997).","journal-title":"Br. J. Pharm."},{"key":"2531_CR293","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3389\/fphys.2018.00486","volume":"9","author":"RV Reyes","year":"2018","unstructured":"Reyes, R. V. et al. Revisiting the role of TRP, Orai, and ASIC channels in the pulmonary arterial response to hypoxia. Front. Physiol. 9, 486 (2018).","journal-title":"Front. Physiol."},{"key":"2531_CR294","doi-asserted-by":"publisher","first-page":"17074","DOI":"10.1038\/cddiscovery.2017.74","volume":"3","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. Orai1, 2, 3 and STIM1 promote store-operated calcium entry in pulmonary arterial smooth muscle cells. Cell Death Discov. 3, 17074 (2017).","journal-title":"Cell Death Discov."},{"key":"2531_CR295","doi-asserted-by":"publisher","first-page":"C504","DOI":"10.1152\/ajpcell.00272.2017","volume":"314","author":"X He","year":"2018","unstructured":"He, X. et al. Hypoxia selectively upregulates cation channels and increases cytosolic [Ca(2+)] in pulmonary, but not coronary, arterial smooth muscle cells. Am. J. Physiol. Cell Physiol. 314, C504\u2013C517 (2018).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2531_CR296","doi-asserted-by":"publisher","first-page":"L477","DOI":"10.1152\/ajplung.00138.2016","volume":"312","author":"TX Chen","year":"2017","unstructured":"Chen, T. X. et al. Hydrogen peroxide is a critical regulator of the hypoxia-induced alterations of store-operated Ca(2+) entry into rat pulmonary arterial smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 312, L477\u2013L487 (2017).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR297","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1152\/physiol.00016.2018","volume":"33","author":"B Rode","year":"2018","unstructured":"Rode, B., Bailey, M. A., Marthan, R., Beech, D. J. & Guibert, C. ORAI channels as potential therapeutic targets in pulmonary hypertension. Physiology 33, 261\u2013268 (2018).","journal-title":"Physiology"},{"key":"2531_CR298","doi-asserted-by":"publisher","first-page":"204589321774142","DOI":"10.1177\/2045893217741429","volume":"8","author":"V Nadeau","year":"2018","unstructured":"Nadeau, V. et al. Dual ET(A)\/ET(B) blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension. Pulm. Circ. 8, 2045893217741429 (2018).","journal-title":"Pulm. Circ."},{"key":"2531_CR299","doi-asserted-by":"publisher","first-page":"610474","DOI":"10.1155\/2014\/610474","volume":"2014","author":"P Siques","year":"2014","unstructured":"Siques, P. et al. Nitric oxide and superoxide anion balance in rats exposed to chronic and long term intermittent hypoxia. Biomed. Res. Int. 2014, 610474 (2014).","journal-title":"Biomed. Res. Int."},{"key":"2531_CR300","doi-asserted-by":"publisher","first-page":"6578578","DOI":"10.1155\/2016\/6578578","volume":"2016","author":"N Luneburg","year":"2016","unstructured":"Luneburg, N. et al. Long-TErm chronic intermittent hypobaric hypoxia in rats causes an imbalance in the asymmetric dimethylarginine\/nitric oxide pathway and ros activity: a possible synergistic mechanism for altitude pulmonary hypertension?. Pulm. Med. 2016, 6578578 (2016).","journal-title":"Pulm. Med."},{"key":"2531_CR301","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.3390\/ijms21228576","volume":"21","author":"E Pena","year":"2020","unstructured":"Pena, E. et al. Nox2 upregulation and p38alpha MAPK activation in right ventricular hypertrophy of rats exposed to long-term chronic intermittent hypobaric hypoxia. Int. J. Mol. Sci. 21, 8576 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2531_CR302","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1089\/ham.2019.0143","volume":"21","author":"X Pu","year":"2020","unstructured":"Pu, X. et al. Oxidative and endoplasmic reticulum stress responses to chronic high-altitude exposure during the development of high-altitude pulmonary hypertension. High. Alt. Med Biol. 21, 378\u2013387 (2020).","journal-title":"High. Alt. Med Biol."},{"key":"2531_CR303","doi-asserted-by":"crossref","unstructured":"Zhang, P. et al. Novel insights into plasma biomarker candidates in patients with chronic mountain sickness based on proteomics. Biosci. Rep. 41 (2021).","DOI":"10.1042\/BSR20202219"},{"key":"2531_CR304","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1089\/ars.2009.2862","volume":"12","author":"JR Desireddi","year":"2010","unstructured":"Desireddi, J. R., Farrow, K. N., Marks, J. D., Waypa, G. B. & Schumacker, P. T. Hypoxia increases ROS signaling and cytosolic Ca(2+) in pulmonary artery smooth muscle cells of mouse lungs slices. Antioxid. Redox Signal 12, 595\u2013602 (2010).","journal-title":"Antioxid. Redox Signal"},{"key":"2531_CR305","doi-asserted-by":"publisher","first-page":"108942","DOI":"10.1016\/j.cbi.2020.108942","volume":"317","author":"Y He","year":"2020","unstructured":"He, Y. et al. Apigenin attenuates pulmonary hypertension by inducing mitochondria-dependent apoptosis of PASMCs via inhibiting the hypoxia inducible factor 1\u03b1\u2013KV1. 5 channel pathway. Chem.-Biol. Interact. 317, 108942 (2020).","journal-title":"Chem.-Biol. Interact."},{"key":"2531_CR306","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3109\/1061186X.2015.1036276","volume":"23","author":"S Guo","year":"2015","unstructured":"Guo, S. & Chen, X. The human Nox4: gene, structure, physiological function and pathological significance. J. Drug Target 23, 888\u2013896 (2015).","journal-title":"J. Drug Target"},{"key":"2531_CR307","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCRESAHA.107.148015","volume":"101","author":"M Mittal","year":"2007","unstructured":"Mittal, M. et al. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ. Res. 101, 258\u2013267 (2007).","journal-title":"Circ. Res."},{"key":"2531_CR308","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1161\/ATVBAHA.114.303848","volume":"34","author":"SA Barman","year":"2014","unstructured":"Barman, S. A. et al. NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling. Arterioscler Thromb. Vasc. Biol. 34, 1704\u20131715 (2014).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"2531_CR309","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/FJC.0b013e31821f2773","volume":"58","author":"DJ Klemm","year":"2011","unstructured":"Klemm, D. J. et al. Reduction of reactive oxygen species prevents hypoxia-induced CREB depletion in pulmonary artery smooth muscle cells. J. Cardiovasc. Pharm. 58, 181\u2013191 (2011).","journal-title":"J. Cardiovasc. Pharm."},{"key":"2531_CR310","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1128\/MCB.05124-11","volume":"31","author":"PT Mungai","year":"2011","unstructured":"Mungai, P. T. et al. Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels. Mol. Cell Biol. 31, 3531\u20133545 (2011).","journal-title":"Mol. Cell Biol."},{"key":"2531_CR311","doi-asserted-by":"publisher","first-page":"101042","DOI":"10.1016\/j.gendis.2023.06.014","volume":"11","author":"J Li","year":"2024","unstructured":"Li, J. et al. LncRNAs are involved in regulating ageing and age-related disease through the adenosine monophosphate-activated protein kinase signalling pathway. Genes Dis. 11, 101042 (2024).","journal-title":"Genes Dis."},{"key":"2531_CR312","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","volume":"45","author":"D Carling","year":"2017","unstructured":"Carling, D. AMPK signalling in health and disease. Curr. Opin. Cell Biol. 45, 31\u201337 (2017).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2531_CR313","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/0-387-31311-7_22","volume":"580","author":"AM Evans","year":"2006","unstructured":"Evans, A. M. et al. Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to pulmonary artery constriction?. Adv. Exp. Med Biol. 580, 147\u2013154 (2006).","journal-title":"Adv. Exp. Med Biol."},{"key":"2531_CR314","doi-asserted-by":"publisher","first-page":"41504","DOI":"10.1074\/jbc.M510040200","volume":"280","author":"AM Evans","year":"2005","unstructured":"Evans, A. M. et al. Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells?. J. Biol. Chem. 280, 41504\u201341511 (2005).","journal-title":"J. Biol. Chem."},{"key":"2531_CR315","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1749-6632.2009.05041.x","volume":"1177","author":"AM Evans","year":"2009","unstructured":"Evans, A. M. et al. Ion channel regulation by AMPK: the route of hypoxia-response coupling in thecarotid body and pulmonary artery. Ann. N. Y Acad. Sci. 1177, 89\u2013100 (2009).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"2531_CR316","doi-asserted-by":"crossref","unstructured":"Moral-Sanz, J. et al. The LKB1-AMPK-alpha1 signaling pathway triggers hypoxic pulmonary vasoconstriction downstream of mitochondria. Sci. Signal. 11 (2018).","DOI":"10.1126\/scisignal.aau0296"},{"key":"2531_CR317","doi-asserted-by":"publisher","first-page":"C1540","DOI":"10.1152\/ajpcell.2000.279.5.C1540","volume":"279","author":"O Platoshyn","year":"2000","unstructured":"Platoshyn, O. et al. Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation. Am. J. Physiol. Cell Physiol. 279, C1540\u20131549 (2000).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2531_CR318","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/385260a0","volume":"385","author":"GE Hardingham","year":"1997","unstructured":"Hardingham, G. E., Chawla, S., Johnson, C. M. & Bading, H. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385, 260\u2013265 (1997).","journal-title":"Nature"},{"key":"2531_CR319","doi-asserted-by":"publisher","first-page":"L887","DOI":"10.1152\/ajplung.2001.281.4.L887","volume":"281","author":"S Krick","year":"2001","unstructured":"Krick, S., Platoshyn, O., McDaniel, S. S., Rubin, L. J. & Yuan, J. X. Augmented K(+) currents and mitochondrial membrane depolarization in pulmonary artery myocyte apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L887\u2013894 (2001).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR320","doi-asserted-by":"publisher","first-page":"L1059","DOI":"10.1152\/ajplung.00448.2004","volume":"288","author":"J Wang","year":"2005","unstructured":"Wang, J. et al. Acute hypoxia increases intracellular [Ca2+] in pulmonary arterial smooth muscle by enhancing capacitative Ca2+ entry. Am. J. Physiol. Lung Cell Mol. Physiol. 288, L1059\u20131069 (2005).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR321","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1113\/jphysiol.2004.078311","volume":"563","author":"LC Ng","year":"2005","unstructured":"Ng, L. C., Wilson, S. M. & Hume, J. R. Mobilization of sarcoplasmic reticulum stores by hypoxia leads to consequent activation of capacitative Ca2+ entry in isolated canine pulmonary arterial smooth muscle cells. J. Physiol. 563, 409\u2013419 (2005).","journal-title":"J. Physiol."},{"key":"2531_CR322","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/01.RES.0000138952.16382.ad","volume":"95","author":"MJ Lin","year":"2004","unstructured":"Lin, M. J. et al. Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ. Res. 95, 496\u2013505 (2004).","journal-title":"Circ. Res."},{"key":"2531_CR323","first-page":"L574","volume":"275","author":"TM Moore","year":"1998","unstructured":"Moore, T. M. et al. Store-operated calcium entry promotes shape change in pulmonary endothelial cells expressing Trp1. Am. J. Physiol. 275, L574\u2013582 (1998).","journal-title":"Am. J. Physiol."},{"key":"2531_CR324","doi-asserted-by":"publisher","first-page":"L1233","DOI":"10.1152\/ajplung.00445.2002","volume":"285","author":"I Fantozzi","year":"2003","unstructured":"Fantozzi, I. et al. Hypoxia increases AP-1 binding activity by enhancing capacitative Ca2+ entry in human pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L1233\u20131245 (2003).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR325","doi-asserted-by":"crossref","unstructured":"El Alam, S., Pena, E., Aguilera, D., Siques, P. & Brito, J. Inflammation in pulmonary hypertension and edema induced by hypobaric hypoxia exposure. Int. J. Mol. Sci. 23 (2022).","DOI":"10.3390\/ijms232012656"},{"key":"2531_CR326","doi-asserted-by":"publisher","first-page":"L238","DOI":"10.1152\/ajplung.90591.2008","volume":"297","author":"DL Burke","year":"2009","unstructured":"Burke, D. L. et al. Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L238\u2013250 (2009).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR327","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","volume":"124","author":"M Grunewald","year":"2006","unstructured":"Grunewald, M. et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, 175\u2013189 (2006).","journal-title":"Cell"},{"key":"2531_CR328","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/path.953","volume":"195","author":"RM Tuder","year":"2001","unstructured":"Tuder, R. M. et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J. Pathol. 195, 367\u2013374 (2001).","journal-title":"J. Pathol."},{"key":"2531_CR329","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1096\/fj.00-0343com","volume":"15","author":"L Taraseviciene-Stewart","year":"2001","unstructured":"Taraseviciene-Stewart, L. et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J. 15, 427\u2013438 (2001).","journal-title":"FASEB J."},{"key":"2531_CR330","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1161\/ATVBAHA.115.306710","volume":"36","author":"RA Johns","year":"2016","unstructured":"Johns, R. A. et al. Hypoxia-Inducible Factor 1alpha Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1\/RELMalpha)-Induced Pulmonary Hypertension. Arterioscler Thromb. Vasc. Biol. 36, 134\u2013144 (2016).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"2531_CR331","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ebiom.2018.06.003","volume":"33","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. IL-33 initiates vascular remodelling in hypoxic pulmonary hypertension by up-regulating HIF-1alpha and VEGF expression in vascular endothelial cells. EBioMedicine 33, 196\u2013210 (2018).","journal-title":"EBioMedicine"},{"key":"2531_CR332","doi-asserted-by":"publisher","first-page":"e141467","DOI":"10.1172\/JCI141467","volume":"131","author":"KV Woo","year":"2021","unstructured":"Woo, K. V. et al. Endothelial FGF signaling is protective in hypoxia-induced pulmonary hypertension. J. Clin. Investig. 131, e141467 (2021).","journal-title":"J. Clin. Investig."},{"key":"2531_CR333","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1165\/rcmb.2023-0355OC","volume":"72","author":"X Zou","year":"2025","unstructured":"Zou, X. et al. SOX17 prevents endothelial-mesenchymal transition of pulmonary arterial endothelial cells in pulmonary hypertension through mediating TGF-beta\/Smad2\/3 Signaling. Am. J. Respir. Cell Mol. Biol. 72, 364\u2013379 (2025).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2531_CR334","doi-asserted-by":"crossref","unstructured":"Moustardas, P., Aberdam, D. & Lagali, N. MAPK pathways in ocular pathophysiology: potential therapeutic drugs and challenges. Cells. 12 (2023).","DOI":"10.3390\/cells12040617"},{"key":"2531_CR335","doi-asserted-by":"publisher","first-page":"L367","DOI":"10.1152\/ajplung.00114.2005","volume":"290","author":"IR Preston","year":"2006","unstructured":"Preston, I. R., Hill, N. S., Warburton, R. R. & Fanburg, B. L. Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L367\u2013374 (2006).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR336","doi-asserted-by":"publisher","first-page":"840737","DOI":"10.1155\/2012\/840737","volume":"2012","author":"B Zhang","year":"2012","unstructured":"Zhang, B. et al. Role of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension. Mediators Inflamm. 2012, 840737 (2012).","journal-title":"Mediators Inflamm."},{"key":"2531_CR337","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1007\/s11033-014-3272-9","volume":"41","author":"X Huang","year":"2014","unstructured":"Huang, X. et al. Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies. Mol. Biol. Rep. 41, 4031\u20134041 (2014).","journal-title":"Mol. Biol. Rep."},{"key":"2531_CR338","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1161\/CIRCRESAHA.115.308178","volume":"119","author":"J Omura","year":"2016","unstructured":"Omura, J. et al. Protective roles of endothelial AMP-activated protein kinase against hypoxia-induced pulmonary hypertension in mice. Circ. Res. 119, 197\u2013209 (2016).","journal-title":"Circ. Res."},{"key":"2531_CR339","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1165\/rcmb.2012-0446OC","volume":"49","author":"JC Ibe","year":"2013","unstructured":"Ibe, J. C. et al. Adenosine monophosphate-activated protein kinase is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 49, 609\u2013618 (2013).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2531_CR340","first-page":"12","volume":"8","author":"M Chen","year":"2016","unstructured":"Chen, M. et al. Salidroside exerts protective effects against chronic hypoxia-induced pulmonary arterial hypertension via AMPKalpha1-dependent pathways. Am. J. Transl. Res. 8, 12\u201327 (2016).","journal-title":"Am. J. Transl. Res."},{"key":"2531_CR341","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s13105-020-00742-4","volume":"76","author":"HL Wang","year":"2020","unstructured":"Wang, H. L. et al. AMPKalpha2 deficiency exacerbates hypoxia-induced pulmonary hypertension by promoting pulmonary arterial smooth muscle cell proliferation. J. Physiol. Biochem. 76, 445\u2013456 (2020).","journal-title":"J. Physiol. Biochem."},{"key":"2531_CR342","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06376-x","volume":"9","author":"J Dai","year":"2018","unstructured":"Dai, J. et al. Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathway. Nat. Commun. 9, 3850 (2018).","journal-title":"Nat. Commun."},{"key":"2531_CR343","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1172\/JCI5912","volume":"103","author":"AY Yu","year":"1999","unstructured":"Yu, A. Y. et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J. Clin. Investig. 103, 691\u2013696 (1999).","journal-title":"J. Clin. Investig."},{"key":"2531_CR344","doi-asserted-by":"crossref","unstructured":"Hu, C. J. et al. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension. Eur. Respir. J. 54 (2019).","DOI":"10.1183\/13993003.00378-2019"},{"key":"2531_CR345","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1172\/JCI15496","volume":"111","author":"K Brusselmans","year":"2003","unstructured":"Brusselmans, K. et al. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J. Clin. Invest 111, 1519\u20131527 (2003).","journal-title":"J. Clin. Invest"},{"key":"2531_CR346","doi-asserted-by":"publisher","first-page":"8801","DOI":"10.1073\/pnas.1602978113","volume":"113","author":"AS Cowburn","year":"2016","unstructured":"Cowburn, A. S. et al. HIF2alpha-arginase axis is essential for the development of pulmonary hypertension. Proc. Natl. Acad. Sci. USA 113, 8801\u20138806 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2531_CR347","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1161\/CIRCULATIONAHA.116.021494","volume":"133","author":"Z Dai","year":"2016","unstructured":"Dai, Z., Li, M., Wharton, J., Zhu, M. M. & Zhao, Y. Y. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2alpha. Circulation 133, 2447\u20132458 (2016).","journal-title":"Circulation"},{"key":"2531_CR348","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1128\/MCB.01055-15","volume":"36","author":"PP Kapitsinou","year":"2016","unstructured":"Kapitsinou, P. P. et al. The endothelial prolyl-4-hydroxylase domain 2\/hypoxia-inducible factor 2 axis regulates pulmonary artery pressure in mice. Mol. Cell Biol. 36, 1584\u20131594 (2016).","journal-title":"Mol. Cell Biol."},{"key":"2531_CR349","first-page":"L256","volume":"314","author":"H Tang","year":"2018","unstructured":"Tang, H. et al. Endothelial HIF-2alpha contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition. Am. J. Physiol. Lung Cell Mol. Physiol. 314, L256\u2013L275 (2018).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2531_CR350","doi-asserted-by":"publisher","first-page":"e14025","DOI":"10.14814\/phy2.14025","volume":"7","author":"H Kojima","year":"2019","unstructured":"Kojima, H. et al. Hypoxia-inducible factor-1 alpha deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension. Physiol. Rep. 7, e14025 (2019).","journal-title":"Physiol. Rep."},{"key":"2531_CR351","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.tjem.2019.09.002","volume":"19","author":"G Aksel","year":"2019","unstructured":"Aksel, G., Corbacioglu, S. K. & Ozen, C. High-altitude illness: management approach. Turk. J. Emerg. Med. 19, 121\u2013126 (2019).","journal-title":"Turk. J. Emerg. Med."},{"key":"2531_CR352","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.smhs.2021.04.001","volume":"3","author":"M Burtscher","year":"2021","unstructured":"Burtscher, M., Hefti, U. & Hefti, J. P. High-altitude illnesses: old stories and new insights into the pathophysiology, treatment and prevention. Sports Med. Health Sci. 3, 59\u201369 (2021).","journal-title":"Sports Med. Health Sci."},{"key":"2531_CR353","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/ham.2008.1043","volume":"10","author":"KE Bloch","year":"2009","unstructured":"Bloch, K. E. et al. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. High. Alt. Med. Biol. 10, 25\u201332 (2009).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR354","first-page":"CD013315","volume":"4","author":"D Molano Franco","year":"2019","unstructured":"Molano Franco, D., Nieto Estrada, V. H., Gonzalez Garay, A. G., Marti-Carvajal, A. J. & Arevalo-Rodriguez, I. Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions. Cochrane Database Syst. Rev. 4, CD013315 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2531_CR355","unstructured":"Committee to Advise on Tropical, M. & Travel Statement on high-altitude illnesses. An Advisory Committee Statement (ACS). Can. Commun. Dis. Rep. 33, 1\u201320 (2007)."},{"key":"2531_CR356","first-page":"942","volume":"59","author":"RL Burse","year":"1988","unstructured":"Burse, R. L. & Forte, V. A. Jr Acute mountain sickness at 4500 m is not altered by repeated eight-hour exposures to 3200-3550 m normobaric hypoxic equivalent. Aviat. Space Environ. Med 59, 942\u2013949 (1988).","journal-title":"Aviat. Space Environ. Med"},{"key":"2531_CR357","doi-asserted-by":"publisher","first-page":"322","DOI":"10.5271\/sjweh.801","volume":"30","author":"JC Launay","year":"2004","unstructured":"Launay, J. C., Nespoulos, O., Guinet-Lebreton, A., Besnard, Y. & Savourey, G. Prevention of acute mountain sickness by low positive end-expiratory pressure in field conditions. Scand. J. Work Environ. Health 30, 322\u2013326 (2004).","journal-title":"Scand. J. Work Environ. Health"},{"key":"2531_CR358","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.wem.2014.04.004","volume":"25","author":"C Dehnert","year":"2014","unstructured":"Dehnert, C., Bohm, A., Grigoriev, I., Menold, E. & Bartsch, P. Sleeping in moderate hypoxia at home for prevention of acute mountain sickness (AMS): a placebo-controlled, randomized double-blind study. Wilderness Environ. Med. 25, 263\u2013271 (2014).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR359","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/ham.2009.1019","volume":"11","author":"K Schommer","year":"2010","unstructured":"Schommer, K. et al. Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m. High. Alt. Med. Biol. 11, 19\u201325 (2010).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR360","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/CS20030161","volume":"106","author":"BA Beidleman","year":"2004","unstructured":"Beidleman, B. A. et al. Intermittent altitude exposures reduce acute mountain sickness at 4300 m. Clin. Sci. 106, 321\u2013328 (2004).","journal-title":"Clin. Sci."},{"key":"2531_CR361","doi-asserted-by":"publisher","first-page":"R428","DOI":"10.1152\/ajpregu.00633.2010","volume":"300","author":"CS Fulco","year":"2011","unstructured":"Fulco, C. S. et al. Effect of repeated normobaric hypoxia exposures during sleep on acute mountain sickness, exercise performance, and sleep during exposure to terrestrial altitude. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R428\u2013436 (2011).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2531_CR362","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1111\/j.1600-0838.2012.01499.x","volume":"22","author":"M Wille","year":"2012","unstructured":"Wille, M. et al. Short-term intermittent hypoxia reduces the severity of acute mountain sickness. Scand. J. Med. Sci. Sports 22, e79\u201385 (2012).","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"2531_CR363","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3389\/fphys.2018.01552","volume":"9","author":"A Akunov","year":"2018","unstructured":"Akunov, A., Sydykov, A., Toktash, T., Doolotova, A. & Sarybaev, A. Hemoglobin changes after long-term intermittent work at high altitude. Front Physiol. 9, 1552 (2018).","journal-title":"Front Physiol."},{"key":"2531_CR364","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1089\/ham.2007.8310","volume":"8","author":"J Brito","year":"2007","unstructured":"Brito, J. et al. Chronic intermittent hypoxia at high altitude exposure for over 12 years: assessment of hematological, cardiovascular, and renal effects. High. Alt. Med. Biol. 8, 236\u2013244 (2007).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR365","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1042\/CS20231508","volume":"138","author":"S Li","year":"2024","unstructured":"Li, S. et al. Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4\/H2O2\/PPAR-gamma axis. Clin. Sci. 138, 103\u2013115 (2024).","journal-title":"Clin. Sci."},{"key":"2531_CR366","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000533RR","volume":"35","author":"Q Lyu","year":"2021","unstructured":"Lyu, Q. et al. Intermittent short-duration reoxygenation protects against simulated high altitude-induced pulmonary hypertension in rats. FASEB J. 35, e21212 (2021).","journal-title":"FASEB J."},{"key":"2531_CR367","doi-asserted-by":"publisher","first-page":"e6779","DOI":"10.1136\/bmj.e6779","volume":"345","author":"EV Low","year":"2012","unstructured":"Low, E. V., Avery, A. J., Gupta, V., Schedlbauer, A. & Grocott, M. P. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. BMJ 345, e6779 (2012).","journal-title":"BMJ"},{"key":"2531_CR368","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/ham.2007.1037","volume":"9","author":"B Kayser","year":"2008","unstructured":"Kayser, B., Hulsebosch, R. & Bosch, F. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness. High. Alt. Med. Biol. 9, 15\u201323 (2008).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR369","first-page":"CD009761","volume":"6","author":"VH Nieto Estrada","year":"2017","unstructured":"Nieto Estrada, V. H. et al. Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs. Cochrane Database Syst. Rev. 6, CD009761 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2531_CR370","first-page":"730","volume":"16","author":"TH Maren","year":"1977","unstructured":"Maren, T. H., Haywood, J. R., Chapman, S. K. & Zimmerman, T. J. The pharmacology of methazolamide in relation to the treatment of glaucoma. Investig. Ophthalmol. Vis. Sci. 16, 730\u2013742 (1977).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"2531_CR371","first-page":"619","volume":"54","author":"AD Wright","year":"1983","unstructured":"Wright, A. D., Bradwell, A. R. & Fletcher, R. F. Methazolamide and acetazolamide in acute mountain sickness. Aviat. Space Environ. Med. 54, 619\u2013621 (1983).","journal-title":"Aviat. Space Environ. Med."},{"key":"2531_CR372","first-page":"523","volume":"22","author":"JH Lee","year":"2011","unstructured":"Lee, J. H. & Choi, P. C. Comparison of methazolamide and acetazolamide for prevention of acute mountain sickness in adolescents. J. Korean Soc. Emerg. Med. 22, 523\u2013530 (2011).","journal-title":"J. Korean Soc. Emerg. Med."},{"key":"2531_CR373","first-page":"12","volume":"40","author":"G Xu","year":"2018","unstructured":"Xu, G. et al. The effect of methazolamide in the hypoxia tolerance of mice and the prevention of acute mountain sickness. J. Third Mil. Med. Univ. 40, 12\u201316 (2018).","journal-title":"J. Third Mil. Med. Univ."},{"key":"2531_CR374","first-page":"950","volume":"59","author":"PH Hackett","year":"1988","unstructured":"Hackett, P. H. et al. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat. Space Environ. Med. 59, 950\u2013954 (1988).","journal-title":"Aviat. Space Environ. Med."},{"key":"2531_CR375","first-page":"289","volume":"154","author":"AJ Ellsworth","year":"1991","unstructured":"Ellsworth, A. J., Meyer, E. F. & Larson, E. B. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier. West J. Med. 154, 289\u2013293 (1991).","journal-title":"West J. Med."},{"key":"2531_CR376","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/0002-9343(87)90937-5","volume":"83","author":"AJ Ellsworth","year":"1987","unstructured":"Ellsworth, A. J., Larson, E. B. & Strickland, D. A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis. Am. J. Med. 83, 1024\u20131030 (1987).","journal-title":"Am. J. Med."},{"key":"2531_CR377","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJM198403153101103","volume":"310","author":"TS Johnson","year":"1984","unstructured":"Johnson, T. S. et al. Prevention of acute mountain sickness by dexamethasone. N. Engl. J. Med. 310, 683\u2013686 (1984).","journal-title":"N. Engl. J. Med."},{"key":"2531_CR378","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijcard.2014.03.019","volume":"173","author":"E Tang","year":"2014","unstructured":"Tang, E., Chen, Y. & Luo, Y. Dexamethasone for the prevention of acute mountain sickness: systematic review and meta-analysis. Int. J. Cardiol. 173, 133\u2013138 (2014).","journal-title":"Int. J. Cardiol."},{"key":"2531_CR379","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.annemergmed.2012.01.019","volume":"59","author":"GS Lipman","year":"2012","unstructured":"Lipman, G. S. et al. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann. Emerg. Med. 59, 484\u2013490 (2012).","journal-title":"Ann. Emerg. Med."},{"key":"2531_CR380","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.wem.2012.08.001","volume":"23","author":"JH Gertsch","year":"2012","unstructured":"Gertsch, J. H. et al. Altitude sickness in climbers and efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. Wilderness Environ. Med. 23, 307\u2013315 (2012).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR381","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.wem.2010.06.009","volume":"21","author":"JH Gertsch","year":"2010","unstructured":"Gertsch, J. H. et al. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT). Wilderness Environ. Med. 21, 236\u2013243 (2010).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR382","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.amjmed.2018.10.021","volume":"132","author":"P Burns","year":"2019","unstructured":"Burns, P. et al. Altitude sickness prevention with ibuprofen relative to acetazolamide. Am. J. Med 132, 247\u2013251 (2019).","journal-title":"Am. J. Med"},{"key":"2531_CR383","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1046\/j.1365-2125.2002.01636.x","volume":"54","author":"SC Lewis","year":"2002","unstructured":"Lewis, S. C. et al. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br. J. Clin. Pharm. 54, 320\u2013326 (2002).","journal-title":"Br. J. Clin. Pharm."},{"issue":"Suppl 1","key":"2531_CR384","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1055\/s-2007-1024598","volume":"13","author":"O Oelz","year":"1992","unstructured":"Oelz, O. et al. Prevention and treatment of high altitude pulmonary edema by a calcium channel blocker. Int. J. Sports Med. 13(Suppl 1), S65\u201368 (1992).","journal-title":"Int. J. Sports Med."},{"key":"2531_CR385","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1580\/06-WEME-OR-062R2.1","volume":"18","author":"FA Moraga","year":"2007","unstructured":"Moraga, F. A., Flores, A., Serra, J., Esnaola, C. & Barriento, C. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollague (3696 m) in northern Chile. Wilderness Environ. Med. 18, 251\u2013257 (2007).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR386","first-page":"445","volume":"67","author":"JP Roncin","year":"1996","unstructured":"Roncin, J. P., Schwartz, F. & D\u2019Arbigny, P. EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. Aviat. Space Environ. Med 67, 445\u2013452 (1996).","journal-title":"Aviat. Space Environ. Med"},{"key":"2531_CR387","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/bmj.38043.501690.7C","volume":"328","author":"JH Gertsch","year":"2004","unstructured":"Gertsch, J. H., Basnyat, B., Johnson, E. W., Onopa, J. & Holck, P. S. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ 328, 797 (2004).","journal-title":"BMJ"},{"key":"2531_CR388","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1001\/archinte.165.3.296","volume":"165","author":"T Chow","year":"2005","unstructured":"Chow, T. et al. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Arch. Intern Med. 165, 296\u2013301 (2005).","journal-title":"Arch. Intern Med."},{"key":"2531_CR389","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1580\/08-WEME-BR-247.1","volume":"20","author":"G Leadbetter","year":"2009","unstructured":"Leadbetter, G. et al. Ginkgo biloba does-and does not-prevent acute mountain sickness. Wilderness Environ. Med. 20, 66\u201371 (2009).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR390","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fphar.2020.00422","volume":"11","author":"A Shaito","year":"2020","unstructured":"Shaito, A. et al. Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety. Front Pharm. 11, 422 (2020).","journal-title":"Front Pharm."},{"key":"2531_CR391","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/1472-6882-13-298","volume":"13","author":"TF Chiu","year":"2013","unstructured":"Chiu, T. F. et al. Rhodiola crenulata extract for prevention of acute mountain sickness: a randomized, double-blind, placebo-controlled, crossover trial. BMC Complement Alter. Med. 13, 298 (2013).","journal-title":"BMC Complement Alter. Med."},{"key":"2531_CR392","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.rce.2019.12.013","volume":"221","author":"E Garrido","year":"2021","unstructured":"Garrido, E., Botella de Maglia, J. & Castillo, O. Acute, subacute and chronic mountain sickness. Rev. Clin. Esp. 221, 481\u2013490 (2021).","journal-title":"Rev. Clin. Esp."},{"key":"2531_CR393","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00011-012-0545-4","volume":"62","author":"D Li","year":"2013","unstructured":"Li, D. et al. Salidroside attenuates inflammatory responses by suppressing nuclear factor-kappaB and mitogen activated protein kinases activation in lipopolysaccharide-induced mastitis in mice. Inflamm. Res. 62, 9\u201315 (2013).","journal-title":"Inflamm. Res."},{"key":"2531_CR394","doi-asserted-by":"publisher","first-page":"574524","DOI":"10.1093\/ecam\/nep199","volume":"2011","author":"J Purushothaman","year":"2011","unstructured":"Purushothaman, J. et al. Modulation of Hypoxia-Induced Pulmonary Vascular Leakage in Rats by Seabuckthorn (Hippophae rhamnoides L.). Evid. Based Complement Altern. Med. 2011, 574524 (2011).","journal-title":"Evid. Based Complement Altern. Med."},{"key":"2531_CR395","first-page":"1291","volume":"36","author":"H Le","year":"2011","unstructured":"Le, H., Qi-quan, Z., Bin-feng, H., Guan-song, W. & Chang-Hua, H. Intervention of sodium aescinate on experimental pneumonedema of rats. Jie Fang. Jun. Yi Xue Za Zhi 36, 1291 (2011).","journal-title":"Jie Fang. Jun. Yi Xue Za Zhi"},{"key":"2531_CR396","doi-asserted-by":"publisher","first-page":"296063","DOI":"10.1155\/2014\/296063","volume":"2014","author":"MA Alam","year":"2014","unstructured":"Alam, M. A. et al. Evaluation of antioxidant compounds, antioxidant activities, and mineral composition of 13 collected purslane (Portulaca oleracea L.) accessions. Biomed. Res. Int. 2014, 296063 (2014).","journal-title":"Biomed. Res. Int."},{"key":"2531_CR397","first-page":"704","volume":"40","author":"L Fei","year":"2015","unstructured":"Fei, L. et al. Protective effect of phenylethanoid glycosides extracted from Phlomis younghusbandii on acute high altitude pulmonary edema in rats. Jie Fang. Jun. Yi Xue Za Zhi 40, 704 (2015).","journal-title":"Jie Fang. Jun. Yi Xue Za Zhi"},{"key":"2531_CR398","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.intimp.2016.09.010","volume":"40","author":"C Wang","year":"2016","unstructured":"Wang, C. et al. Protective effects of puerarin on acute lung and cerebrum injury induced by hypobaric hypoxia via the regulation of aquaporin (AQP) via NF-kappaB signaling pathway. Int Immunopharmacol. 40, 300\u2013309 (2016).","journal-title":"Int Immunopharmacol."},{"key":"2531_CR399","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1002\/ptr.8333","volume":"38","author":"C Pei","year":"2024","unstructured":"Pei, C. et al. Eleutheroside B pretreatment attenuates hypobaric hypoxia-induced high-altitude pulmonary edema by regulating autophagic flux via the AMPK\/mTOR pathway. Phytother. Res 38, 5657\u20135671 (2024).","journal-title":"Phytother. Res"},{"key":"2531_CR400","doi-asserted-by":"publisher","first-page":"117512","DOI":"10.1016\/j.biopha.2024.117512","volume":"180","author":"D Huang","year":"2024","unstructured":"Huang, D. et al. Pre-treatment with notoginsenoside R1 from Panax notoginseng protects against high-altitude-induced pulmonary edema by inhibiting pyroptosis through the NLRP3\/caspase-1\/GSDMD pathway. Biomed. Pharmacother. 180, 117512 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"2531_CR401","doi-asserted-by":"publisher","first-page":"176065","DOI":"10.1016\/j.ejphar.2023.176065","volume":"959","author":"C Pei","year":"2023","unstructured":"Pei, C. et al. Notoginsenoside R1 protects against hypobaric hypoxia-induced high-altitude pulmonary edema by inhibiting apoptosis via ERK1\/2-P90rsk-BAD ignaling pathway. Eur. J. Pharm. 959, 176065 (2023).","journal-title":"Eur. J. Pharm."},{"key":"2531_CR402","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fphys.2018.00289","volume":"9","author":"C Nydegger","year":"2018","unstructured":"Nydegger, C. et al. Phosphodiesterase-5 Inhibition Alleviates Pulmonary Hypertension and Basal Lamina Thickening in Rats Challenged by Chronic Hypoxia. Front Physiol. 9, 289 (2018).","journal-title":"Front Physiol."},{"key":"2531_CR403","doi-asserted-by":"crossref","unstructured":"Huang, W., Liu, N., Tong, X. & Du, Y. Sildenafil protects against pulmonary hypertension induced by hypoxia in neonatal rats via activation of PPARgamma\u2011mediated downregulation of TRPC. Int. J. Mol. Med. 49 (2022).","DOI":"10.3892\/ijmm.2021.5074"},{"key":"2531_CR404","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/FJC.0000000000001373","volume":"81","author":"L Kang","year":"2023","unstructured":"Kang, L. et al. Sildenafil improves pulmonary vascular remodeling in a rat model of persistent pulmonary hypertension of the newborn. J. Cardiovasc Pharm. 81, 232\u2013239 (2023).","journal-title":"J. Cardiovasc Pharm."},{"key":"2531_CR405","doi-asserted-by":"publisher","first-page":"300060520914218","DOI":"10.1177\/0300060520914218","volume":"48","author":"G Liu","year":"2020","unstructured":"Liu, G., Zhang, Q., Zhang, J. & Zhang, N. Preventive but nontherapeutic effect of danshensu on hypoxic pulmonary hypertension. J. Int. Med Res. 48, 300060520914218 (2020).","journal-title":"J. Int. Med Res."},{"key":"2531_CR406","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.freeradbiomed.2014.01.013","volume":"69","author":"B Zhang","year":"2014","unstructured":"Zhang, B. et al. Oxymatrine prevents hypoxia- and monocrotaline-induced pulmonary hypertension in rats. Free Radic. Biol. Med. 69, 198\u2013207 (2014).","journal-title":"Free Radic. Biol. Med."},{"key":"2531_CR407","first-page":"533","volume":"35","author":"YF Wang","year":"2019","unstructured":"Wang, Y. F. et al. Effects of Salvia przewalskii Maxim. on high-altitude pulmonary hypertension in rats and its mechanism. Zhongguo Ying Yong Sheng Li Xue Za Zhi 35, 533\u2013536 (2019).","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"2531_CR408","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jep.2016.04.004","volume":"186","author":"L Li","year":"2016","unstructured":"Li, L. et al. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats. J. Ethnopharmacol. 186, 224\u2013233 (2016).","journal-title":"J. Ethnopharmacol."},{"key":"2531_CR409","doi-asserted-by":"publisher","first-page":"154329","DOI":"10.1016\/j.phymed.2022.154329","volume":"104","author":"L Ji","year":"2022","unstructured":"Ji, L. et al. Luteolin ameliorates hypoxia-induced pulmonary hypertension via regulating HIF-2alpha-Arg-NO axis and PI3K-AKT-eNOS-NO signaling pathway. Phytomedicine 104, 154329 (2022).","journal-title":"Phytomedicine"},{"key":"2531_CR410","doi-asserted-by":"publisher","first-page":"155840","DOI":"10.1016\/j.phymed.2024.155840","volume":"132","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Luteolin ameliorates hypoxic pulmonary vascular remodeling in rat via upregulating K(V)1.5 of pulmonary artery smooth muscle cells. Phytomedicine 132, 155840 (2024).","journal-title":"Phytomedicine"},{"key":"2531_CR411","doi-asserted-by":"publisher","first-page":"9504158","DOI":"10.1155\/2018\/9504158","volume":"2018","author":"Q He","year":"2018","unstructured":"He, Q. et al. Tsantan Sumtang alleviates chronic hypoxia-induced pulmonary hypertension by inhibiting proliferation of pulmonary vascular cells. Biomed. Res. Int. 2018, 9504158 (2018).","journal-title":"Biomed. Res. Int."},{"key":"2531_CR412","doi-asserted-by":"publisher","first-page":"112470","DOI":"10.1016\/j.jep.2019.112470","volume":"250","author":"Z Dang","year":"2020","unstructured":"Dang, Z. et al. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R\/ACE2-Ang1-7-Mas axis in rat. J. Ethnopharmacol. 250, 112470 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"2531_CR413","doi-asserted-by":"publisher","first-page":"607384","DOI":"10.3389\/fphar.2020.607384","volume":"11","author":"Z Yang","year":"2020","unstructured":"Yang, Z. et al. Tsantan Sumtang restored right ventricular function in chronic hypoxia-induced pulmonary hypertension rats. Front. Pharm. 11, 607384 (2020).","journal-title":"Front. Pharm."},{"key":"2531_CR414","doi-asserted-by":"publisher","first-page":"117436","DOI":"10.1016\/j.jep.2023.117436","volume":"320","author":"N Li","year":"2024","unstructured":"Li, N. et al. Tsantan Sumtang, a traditional Tibetan medicine, protects pulmonary vascular endothelial function of hypoxia-induced pulmonary hypertension rats through AKT\/eNOS signaling pathway. J. Ethnopharmacol. 320, 117436 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"2531_CR415","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jep.2018.01.010","volume":"216","author":"X Nan","year":"2018","unstructured":"Nan, X. et al. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats. J. Ethnopharmacol. 216, 175\u2013183 (2018).","journal-title":"J. Ethnopharmacol."},{"key":"2531_CR416","doi-asserted-by":"publisher","first-page":"114734","DOI":"10.1016\/j.jep.2021.114734","volume":"283","author":"R Zhang","year":"2022","unstructured":"Zhang, R. et al. Pretreatment with the active fraction of Rhodiola tangutica (Maxim.) S.H. Fu rescues hypoxia-induced potassium channel inhibition in rat pulmonary artery smooth muscle cells. J. Ethnopharmacol. 283, 114734 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"2531_CR417","doi-asserted-by":"publisher","first-page":"9650650","DOI":"10.1155\/2022\/9650650","volume":"2022","author":"X Nan","year":"2022","unstructured":"Nan, X. et al. The mechanism of volatile oil of rhodiola tangutica against hypoxia-induced pulmonary hypertension in rats based on RAS pathway. Biomed. Res. Int. 2022, 9650650 (2022).","journal-title":"Biomed. Res. Int."},{"key":"2531_CR418","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jphs.2020.09.002","volume":"144","author":"X Gai","year":"2020","unstructured":"Gai, X. et al. Echinacoside prevents hypoxic pulmonary hypertension by regulating the pulmonary artery function. J. Pharm. Sci. 144, 237\u2013244 (2020).","journal-title":"J. Pharm. Sci."},{"key":"2531_CR419","doi-asserted-by":"publisher","first-page":"115572","DOI":"10.1016\/j.jep.2022.115572","volume":"297","author":"T Chen","year":"2022","unstructured":"Chen, T. et al. Srolo Bzhtang reduces inflammation and vascular remodeling via suppression of the MAPK\/NF-kappaB signaling pathway in rats with pulmonary arterial hypertension. J. Ethnopharmacol. 297, 115572 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"2531_CR420","doi-asserted-by":"publisher","first-page":"116478","DOI":"10.1016\/j.taap.2023.116478","volume":"466","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Kaempferol ameliorates pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension rats via regulating Akt-GSK3beta-cyclin axis. Toxicol. Appl. Pharm. 466, 116478 (2023).","journal-title":"Toxicol. Appl. Pharm."},{"key":"2531_CR421","doi-asserted-by":"publisher","first-page":"116596","DOI":"10.1016\/j.taap.2023.116596","volume":"473","author":"C Gu","year":"2023","unstructured":"Gu, C. et al. 4-Terpineol attenuates pulmonary vascular remodeling via suppressing PI3K\/Akt signaling pathway in hypoxia-induced pulmonary hypertension rats. Toxicol. Appl. Pharm. 473, 116596 (2023).","journal-title":"Toxicol. Appl. Pharm."},{"key":"2531_CR422","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0736-4679(03)00034-9","volume":"24","author":"NS Harris","year":"2003","unstructured":"Harris, N. S., Wenzel, R. P. & Thomas, S. H. High altitude headache: efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial. J. Emerg. Med. 24, 383\u2013387 (2003).","journal-title":"J. Emerg. Med."},{"key":"2531_CR423","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/0140-6736(90)93240-P","volume":"336","author":"P Bartsch","year":"1990","unstructured":"Bartsch, P., Baumgartner, R. W., Waber, U., Maggiorini, M. & Oelz, O. Comparison of carbon-dioxide-enriched, oxygen-enriched, and normal air in treatment of acute mountain sickness. Lancet 336, 772\u2013775 (1990).","journal-title":"Lancet"},{"key":"2531_CR424","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0140-6736(05)60305-4","volume":"352","author":"K Zafren","year":"1998","unstructured":"Zafren, K. Gamow bag for high-altitude cerebral oedema. Lancet 352, 325\u2013326 (1998).","journal-title":"Lancet"},{"key":"2531_CR425","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/bmj.310.6989.1232","volume":"310","author":"HR Keller","year":"1995","unstructured":"Keller, H. R., Maggiorini, M., Bartsch, P. & Oelz, O. Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial. BMJ 310, 1232\u20131235 (1995).","journal-title":"BMJ"},{"key":"2531_CR426","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/bmj.306.6885.1098","volume":"306","author":"P Bartsch","year":"1993","unstructured":"Bartsch, P. et al. Treatment of acute mountain sickness by simulated descent: a randomised controlled trial. BMJ 306, 1098\u20131101 (1993).","journal-title":"BMJ"},{"key":"2531_CR427","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-116-6-461","volume":"116","author":"CK Grissom","year":"1992","unstructured":"Grissom, C. K., Roach, R. C., Sarnquist, F. H. & Hackett, P. H. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann. Intern. Med. 116, 461\u2013465 (1992).","journal-title":"Ann. Intern. Med."},{"key":"2531_CR428","doi-asserted-by":"publisher","first-page":"105326","DOI":"10.1016\/j.ejps.2020.105326","volume":"148","author":"H Lu","year":"2020","unstructured":"Lu, H., Zhang, H. & Jiang, Y. Methazolamide in high-altitude illnesses. Eur. J. Pharm. Sci. 148, 105326 (2020).","journal-title":"Eur. J. Pharm. Sci."},{"key":"2531_CR429","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1056\/NEJM198912213212504","volume":"321","author":"BD Levine","year":"1989","unstructured":"Levine, B. D. et al. Dexamethasone in the treatment of acute mountain sickness. N. Engl. J. Med 321, 1707\u20131713 (1989).","journal-title":"N. Engl. J. Med"},{"key":"2531_CR430","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1136\/bmj.294.6584.1380","volume":"294","author":"G Ferrazzini","year":"1987","unstructured":"Ferrazzini, G., Maggiorini, M., Kriemler, S., Bartsch, P. & Oelz, O. Successful treatment of acute mountain sickness with dexamethasone. Br. Med. J. 294, 1380\u20131382 (1987).","journal-title":"Br. Med. J."},{"key":"2531_CR431","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3736\/jcim20110408","volume":"9","author":"ZF Shi","year":"2011","unstructured":"Shi, Z. F. et al. Three preparations of compound Chinese herbal medicines for de-adaptation to high altitude: a randomized, placebo-controlled trial. Zhong Xi Yi Jie He Xue Bao 9, 395\u2013401 (2011).","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"2531_CR432","doi-asserted-by":"publisher","first-page":"541","DOI":"10.21037\/atm-22-2111","volume":"10","author":"C Cao","year":"2022","unstructured":"Cao, C. et al. The combined use of acetazolamide and Rhodiola in the prevention and treatment of altitude sickness. Ann. Transl. Med. 10, 541 (2022).","journal-title":"Ann. Transl. Med."},{"key":"2531_CR433","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-024-00526-w","volume":"10","author":"H Gatterer","year":"2024","unstructured":"Gatterer, H. et al. Altitude illnesses. Nat. Rev. Dis. Prim. 10, 43 (2024).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2531_CR434","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.wem.2012.07.004","volume":"24","author":"BE Jones","year":"2013","unstructured":"Jones, B. E., Stokes, S., McKenzie, S., Nilles, E. & Stoddard, G. J. Management of high altitude pulmonary edema in the Himalaya: a review of 56 cases presenting at Pheriche medical aid post (4240 m). Wilderness Environ. Med. 24, 32\u201336 (2013).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR435","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/ham.2007.3055","volume":"8","author":"PJ Fagenholz","year":"2007","unstructured":"Fagenholz, P. J., Gutman, J. A., Murray, A. F. & Harris, N. S. Treatment of high altitude pulmonary edema at 4240 m in Nepal. High. Alt. Med. Biol. 8, 139\u2013146 (2007).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR436","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1580\/1080-6032(1996)007[0127:TOHAPE]2.3.CO;2","volume":"7","author":"K Zafren","year":"1996","unstructured":"Zafren, K., Reeves, J. T. & Schoene, R. Treatment of high-altitude pulmonary edema by bed rest and supplemental oxygen. Wilderness Environ. Med. 7, 127\u2013132 (1996).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR437","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1089\/ham.2015.0120","volume":"17","author":"U Yanamandra","year":"2016","unstructured":"Yanamandra, U. et al. Managing high-altitude pulmonary edema with oxygen alone: results of a randomized controlled trial. High. Alt. Med. Biol. 17, 294\u2013299 (2016).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR438","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1580\/1080-6032(2004)15[198:UOTGBB]2.0.CO;2","volume":"15","author":"K Freeman","year":"2004","unstructured":"Freeman, K., Shalit, M. & Stroh, G. Use of the Gamow Bag by EMT-basic park rangers for treatment of high-altitude pulmonary edema and high-altitude cerebral edema. Wilderness Environ. Med. 15, 198\u2013201 (2004).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR439","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.wem.2011.10.003","volume":"23","author":"R Deshwal","year":"2012","unstructured":"Deshwal, R., Iqbal, M. & Basnet, S. Nifedipine for the treatment of high altitude pulmonary edema. Wilderness Environ. Med. 23, 7\u201310 (2012).","journal-title":"Wilderness Environ. Med."},{"key":"2531_CR440","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1378\/chest.87.3.330","volume":"87","author":"RB Schoene","year":"1985","unstructured":"Schoene, R. B., Roach, R. C., Hackett, P. H., Harrison, G. & Mills, W. J. Jr High altitude pulmonary edema and exercise at 4,400 meters on Mount McKinley. Effect of expiratory positive airway pressure. Chest 87, 330\u2013333 (1985).","journal-title":"Chest"},{"key":"2531_CR441","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1089\/ham.2013.1059","volume":"14","author":"M Walmsley","year":"2013","unstructured":"Walmsley, M. Continuous positive airway pressure as adjunct treatment of acute altitude illness. High. Alt. Med. Biol. 14, 405\u2013407 (2013).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR442","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/hrt.29.5.709","volume":"29","author":"I Singh","year":"1967","unstructured":"Singh, I., Lal, M., Khanna, P. K. & Mathew, N. T. Augmentation of frusemide diuresis by morphine in high altitude pulmonary oedema. Br. Heart J. 29, 709\u2013713 (1967).","journal-title":"Br. Heart J."},{"key":"2531_CR443","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1152\/japplphysiol.00076.2023","volume":"134","author":"WFJ Schmidt","year":"2023","unstructured":"Schmidt, W. F. J. et al. Possible strategies to reduce altitude-related excessive polycythemia. J. Appl. Physiol. 134, 1321\u20131331 (2023).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR444","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1152\/japplphysiol.00439.2022","volume":"134","author":"C Anza-Ramirez","year":"2023","unstructured":"Anza-Ramirez, C. et al. Preserved peak exercise capacity in Andean highlanders with excessive erythrocytosis both before and after isovolumic hemodilution. J. Appl. Physiol. 134, 36\u201349 (2023).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR445","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ham.2016.0031","volume":"17","author":"FC Villafuerte","year":"2016","unstructured":"Villafuerte, F. C. & Corante, N. Chronic mountain sickness: clinical aspects, etiology, management, and treatment. High. Alt. Med. Biol. 17, 61\u201369 (2016).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR446","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1152\/jappl.1985.59.5.1495","volume":"59","author":"RM Winslow","year":"1985","unstructured":"Winslow, R. M. et al. Effects of hemodilution on O2 transport in high-altitude polycythemia. J. Appl. Physiol. 59, 1495\u20131502 (1985).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR447","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1001\/jama.2009.1404","volume":"302","author":"TG Smith","year":"2009","unstructured":"Smith, T. G. et al. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA 302, 1444\u20131450 (2009).","journal-title":"JAMA"},{"key":"2531_CR448","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1164\/rccm.200802-196OC","volume":"177","author":"JP Richalet","year":"2008","unstructured":"Richalet, J. P. et al. Acetazolamide for Monge\u2019s disease: efficiency and tolerance of 6-month treatment. Am. J. Respir. Crit. Care Med. 177, 1370\u20131376 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2531_CR449","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/ham.2017.0044","volume":"19","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. Therapeutic efficacy of methazolamide against intermittent hypoxia-induced excessive erythrocytosis in rats. High. Alt. Med. Biol. 19, 69\u201380 (2018).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR450","doi-asserted-by":"crossref","unstructured":"Gonzales-Arimborgo, C. et al. Acceptability, safety, and efficacy of oral administration of extracts of black or red maca (Lepidium meyenii) in adult human subjects: a randomized, double-blind, placebo-controlled study. Pharmaceuticals. 9 (2016).","DOI":"10.3390\/ph9030049"},{"key":"2531_CR451","first-page":"44","volume":"25","author":"ZC Ga","year":"2019","unstructured":"Ga, Z. C. et al. Clinical efficacy of duoxuekang capsule in the treatment of high altitude polycythemia. Zhong Yi Yao Dao. Bao 25, 44\u201347 (2019).","journal-title":"Zhong Yi Yao Dao. Bao"},{"key":"2531_CR452","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/hrt.33.5.647","volume":"33","author":"F Sime","year":"1971","unstructured":"Sime, F., Penaloza, D. & Ruiz, L. Bradycardia, increased cardiac output, and reversal of pulmonary hypertension in altitude natives living at sea level. Br. Heart J. 33, 647\u2013657 (1971).","journal-title":"Br. Heart J."},{"key":"2531_CR453","first-page":"1247","volume":"57","author":"R Fried","year":"1984","unstructured":"Fried, R. & Reid, L. M. Early recovery from hypoxic pulmonary hypertension: a structural and functional study. J. Appl. Physiol. Respir. Environ. Exerc Physiol. 57, 1247\u20131253 (1984).","journal-title":"J. Appl. Physiol. Respir. Environ. Exerc Physiol."},{"key":"2531_CR454","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/0002-9149(66)90443-7","volume":"18","author":"RF Grover","year":"1966","unstructured":"Grover, R. F., Vogel, J. H., Voigt, G. C. & Blount, S. G. Jr Reversal of high altitude pulmonary hypertension. Am. J. Cardiol. 18, 928\u2013932 (1966).","journal-title":"Am. J. Cardiol."},{"key":"2531_CR455","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/thx.2005.041954","volume":"60","author":"AA Aldashev","year":"2005","unstructured":"Aldashev, A. A. et al. Phosphodiesterase type 5 and high altitude pulmonary hypertension. Thorax 60, 683\u2013687 (2005).","journal-title":"Thorax"},{"key":"2531_CR456","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.resp.2008.10.005","volume":"165","author":"RD Seheult","year":"2009","unstructured":"Seheult, R. D., Ruh, K., Foster, G. P. & Anholm, J. D. Prophylactic bosentan does not improve exercise capacity or lower pulmonary artery systolic pressure at high altitude. Respir. Physiol. Neurobiol. 165, 123\u2013130 (2009).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"2531_CR457","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/ham.2011.1107","volume":"13","author":"B Kojonazarov","year":"2012","unstructured":"Kojonazarov, B. et al. Bosentan reduces pulmonary artery pressure in high altitude residents. High. Alt. Med. Biol. 13, 217\u2013223 (2012).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR458","first-page":"47","volume":"15","author":"SY Yang","year":"2008","unstructured":"Yang, S. Y. et al. The relationship between change of serum basic fibroblast growth factor level and pulmonary arterial pressure and its intervention in patients with chronic cor pulmonale at high altitude areas. Clin. Med. J. Chin. 15, 47\u201349 (2008).","journal-title":"Clin. Med. J. Chin."},{"key":"2531_CR459","first-page":"3","volume":"12","author":"EZ Feng","year":"2010","unstructured":"Feng, E. Z. et al. Effects of rhodiola on pulmonary arterial pressure in patients with chronic cor pulmonale in acute exacerbation at high altitude areas and its mechanism. Chin. J. Health Care Med. 12, 3 (2010).","journal-title":"Chin. J. Health Care Med."},{"key":"2531_CR460","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1183\/09031936.00095211","volume":"39","author":"B Kojonazarov","year":"2012","unstructured":"Kojonazarov, B., Myrzaakhmatova, A., Sooronbaev, T., Ishizaki, T. & Aldashev, A. Effects of fasudil in patients with high-altitude pulmonary hypertension. Eur. Respir. J. 39, 496\u2013498 (2012).","journal-title":"Eur. Respir. J."},{"key":"2531_CR461","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1164\/rccm.200505-807OC","volume":"172","author":"JP Richalet","year":"2005","unstructured":"Richalet, J. P. et al. Acetazolamide: a treatment for chronic mountain sickness. Am. J. Respir. Crit. Care Med. 172, 1427\u20131433 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2531_CR462","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1089\/ham.2013.1110","volume":"15","author":"Y Xu","year":"2014","unstructured":"Xu, Y., Liu, Y., Liu, J. & Qian, G. Meta-analysis of clinical efficacy of sildenafil, a phosphodiesterase type-5 inhibitor on high altitude hypoxia and its complications. High. Alt. Med. Biol. 15, 46\u201351 (2014).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR463","unstructured":"Ulloa, N. A. & Cook, J. in StatPearls (2025)."},{"key":"2531_CR464","doi-asserted-by":"crossref","unstructured":"Shlim, D. R. The use of acetazolamide for the prevention of high-altitude illness. J. Travel Med. 27 (2020).","DOI":"10.1093\/jtm\/taz106"},{"key":"2531_CR465","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1753465816677006","volume":"11","author":"HM Liu","year":"2017","unstructured":"Liu, H. M., Chiang, I. J., Kuo, K. N., Liou, C. M. & Chen, C. The effect of acetazolamide on sleep apnea at high altitude: a systematic review and meta-analysis. Ther. Adv. Respir. Dis. 11, 20\u201329 (2017).","journal-title":"Ther. Adv. Respir. Dis."},{"key":"2531_CR466","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jsb.2008.11.010","volume":"166","author":"Y Tanimura","year":"2009","unstructured":"Tanimura, Y., Hiroaki, Y. & Fujiyoshi, Y. Acetazolamide reversibly inhibits water conduction by aquaporin-4. J. Struct. Biol. 166, 16\u201321 (2009).","journal-title":"J. Struct. Biol."},{"key":"2531_CR467","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1152\/japplphysiol.00443.2015","volume":"120","author":"ER Swenson","year":"2016","unstructured":"Swenson, E. R. Pharmacology of acute mountain sickness: old drugs and newer thinking. J. Appl. Physiol. 120, 204\u2013215 (2016).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR468","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1152\/japplphysiol.00391.2011","volume":"111","author":"CG Julian","year":"2011","unstructured":"Julian, C. G. et al. Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study. J. Appl. Physiol. 111, 392\u2013399 (2011).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR469","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/ham.2010.1051","volume":"11","author":"TE Kelly","year":"2010","unstructured":"Kelly, T. E. & Hackett, P. H. Acetazolamide and sulfonamide allergy: a not so simple story. High. Alt. Med. Biol. 11, 319\u2013323 (2010).","journal-title":"High. Alt. Med. Biol."},{"key":"2531_CR470","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1152\/japplphysiol.00509.2018","volume":"125","author":"LM Boulet","year":"2018","unstructured":"Boulet, L. M. et al. Attenuation of human hypoxic pulmonary vasoconstriction by acetazolamide and methazolamide. J. Appl. Physiol. 125, 1795\u20131803 (2018).","journal-title":"J. Appl. Physiol."},{"key":"2531_CR471","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1152\/physiolgenomics.00064.2002","volume":"11","author":"SS Sarang","year":"2002","unstructured":"Sarang, S. S. et al. Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays. Physiol. Genomics 11, 45\u201352 (2002).","journal-title":"Physiol. Genomics"},{"key":"2531_CR472","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.biocel.2012.04.021","volume":"44","author":"SJ Chapple","year":"2012","unstructured":"Chapple, S. J., Siow, R. C. & Mann, G. E. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int. J. Biochem. Cell Biol. 44, 1315\u20131320 (2012).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2531_CR473","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1580\/0953-9859-5.1.49","volume":"5","author":"AD Wright","year":"1994","unstructured":"Wright, A. D. et al. Carbonic anhydrase inhibition in the immediate therapy of acute mountain sickness. Wild Environ. Med. 5, 49\u201355 (1994).","journal-title":"Wild Environ. Med."},{"key":"2531_CR474","first-page":"402","volume":"27","author":"ME Bastin","year":"2006","unstructured":"Bastin, M. E. et al. Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma. AJNR Am. J. Neuroradiol. 27, 402\u2013408 (2006).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"2531_CR475","first-page":"CD009567","volume":"6","author":"D Simancas-Racines","year":"2018","unstructured":"Simancas-Racines, D. et al. Interventions for treating acute high altitude illness. Cochrane Database Syst. Rev. 6, CD009567 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2531_CR476","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/hc2901.093117","volume":"104","author":"L Zhao","year":"2001","unstructured":"Zhao, L. et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 104, 424\u2013428 (2001).","journal-title":"Circulation"},{"key":"2531_CR477","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00894-008-0322-z","volume":"14","author":"GD Chandramoorthi","year":"2008","unstructured":"Chandramoorthi, G. D., Piramanayagam, S. & Marimuthu, P. An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine. J. Mol. Model 14, 849\u2013856 (2008).","journal-title":"J. Mol. Model"},{"key":"2531_CR478","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.pcad.2010.03.001","volume":"52","author":"M Maggiorini","year":"2010","unstructured":"Maggiorini, M. Prevention and treatment of high-altitude pulmonary edema. Prog. Cardiovasc. Dis. 52, 500\u2013506 (2010).","journal-title":"Prog. Cardiovasc. Dis."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02531-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02531-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02531-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:03:55Z","timestamp":1769126635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02531-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":478,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2531"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02531-1","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest. Fengming Luo is one of the Associate Editors of Signal Transduction and Targeted Therapy, but he has not been involved in the process of manuscript handling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}